Renovare Environmental (RENO) 10-K 30 Mar 17 2016 FY Annual report Financial data

Document And Entity Information

Document And Entity Information - USD ($)	12 Months Ended
	Dec. 31, 2016	Mar. 15, 2017	Jun. 30, 2016
Document Information [Line Items]
Document Type	10-K
Amendment Flag	false
Document Period End Date	Dec. 31, 2016
Document Fiscal Year Focus	2,016
Document Fiscal Period Focus	FY
Entity Registrant Name	BIOHITECH GLOBAL, INC.
Entity Central Index Key	1,590,383
Current Fiscal Year End Date	--12-31
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Filer Category	Smaller Reporting Company
Entity Public Float			$ 10,671,964
Trading Symbol	BHTG
Entity Common Stock, Shares Outstanding		8,229,712

Consolidated Statements of Oper

Consolidated Statements of Operations and Comprehensive Loss - USD ($)	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Revenue
Rental, service and parts	$ 1,371,087	$ 1,023,385
Equipment sales	872,379	415,616
Other	0	74,980
Total revenue	2,243,466	1,513,981
Cost of revenue
Rental, service and parts	1,084,251	969,518
Equipment sales	585,673	320,863
Other	0	35,428
Total Cost of revenue	1,669,924	1,325,809
Gross profit	573,542	188,172
Operating expenses
Selling, general and administrative	4,222,152	2,902,465
Research and development	899,400	703,255
Professional fees	1,263,183	1,167,829
Gain on sale of QTags	0	(191,805)
Goodwill impairment	0	10,482
Depreciation and amortization	113,474	141,592
Total operating expenses	6,498,209	4,733,818
Loss from operations	(5,924,667)	(4,545,646)
Other expense (income)
Interest income	0	(8,152)
Interest expense	820,719	465,420
Change in fair value of warrant liability	0	(1,462)
Total other expense	820,719	455,806
Net loss	(6,745,386)	(5,001,452)
Other comprehensive income (loss)
Foreign currency translation adjustment	16,720	(7,801)
Comprehensive loss	$ (6,728,666)	$ (5,009,253)
Net loss per share - basic and diluted	$ (0.82)	$ (0.68)
Weighted average number of common shares outstanding - basic and diluted	8,229,712	7,316,250

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($)	Dec. 31, 2016	Dec. 31, 2015
Current Assets
Cash	$ 325,987	$ 39,195
Accounts and note receivable, net	140,130	316,299
Inventory	706,017	274,304
Prepaid expenses and other current assets	21,865	67,136
Total Current Assets	1,193,999	696,934
Equipment on operating leases, net	1,023,404	844,494
Equipment, fixtures and vehicles, net	54,356	61,688
Intangible assets, net	267,042	365,038
Other assets	13,500	51,600
Total Assets	2,552,301	2,019,754
Current Liabilities:
Line of credit	2,463,736	2,488,753
Accounts payable	1,197,277	1,222,167
Accrued interest payable	411,917	287,888
Accrued expenses	522,727	548,522
Deferred revenue	61,879	48,103
Notes payable	100,000	100,000
Notes payable - related party	275,000	300,000
Advance from related party	1,213,027	710,000
Customer deposits	36,131	29,657
Long-term debt, current portion	8,525	8,260
Total Current Liabilities	6,290,219	5,743,350
Promissory note - related party	2,500,000	1,710,000
Long term accrued interest	253,000	0
Unsecured subordinated convertible notes, including related parties of $3,800,000, net of deferred financing costs of $118,866	4,956,134	0
Long-term debt, net of current portion	11,048	19,573
Total Liabilities	14,010,401	7,472,923
Commitments and Contingencies
Stockholders' Deficit
Preferred stock, $0.0001 par value; 10,000,000 shares authorized; none issued	0	0
Common stock, $0.0001 par value, 20,000,000 shares authorized; 8,229,712 shares issued and outstanding as of December 31, 2016 and 2015	823	823
Additional paid in capital	9,604,324	8,880,589
Accumulated deficit	(21,072,166)	(14,326,780)
Accumulated other comprehensive gain (loss)	8,919	(7,801)
Total Stockholders' Deficit	(11,458,100)	(5,453,169)
Total Liabilities and Stockholders' Deficit	$ 2,552,301	$ 2,019,754

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - USD ($)	Dec. 31, 2016	Dec. 31, 2015
Preferred Stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Preferred Stock, Shares Authorized	10,000,000	10,000,000
Preferred Stock, Shares Issued	0	0
Common Stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized	20,000,000	20,000,000
Common stock, shares issued	8,229,712	8,229,712
Common stock, shares outstanding	8,229,712	8,229,712
Due to Related Parties, Noncurrent	$ 3,800,000
Unamortized Debt Issuance Expense	$ 118,866

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Cash flows from operating activities:
Net loss:	$ (6,745,386)	$ (5,001,452)
Adjustments to reconcile net loss to net cash used in operations:
Depreciation and amortization	457,102	360,268
Provision for bad debts	93,406	39,247
Stock based employee compensation	674,782	0
Fees paid in stock	48,953	175,000
Fees paid in convertible notes	125,000	0
Interest resulting from amortization of financing costs	77,007	0
Gain on sale of QTags	0	(191,805)
Impairment expense	0	10,482
Website write-down	0	4,273
Change in fair value of warrant liability	0	(1,462)
Changes in operating assets and liabilities	87,736	1,435,022
Changes in operating assets and liabilities:
Net cash used in operations	(5,181,400)	(3,170,427)
Cash flow from investing activities:
Proceeds from sale of QTags	0	75,000
Cash acquired from Swift Start	0	18
Purchases of equipment, fixtures and vehicles	(8,146)	(18,320)
Net cash (used in) provided by investing activities	(8,146)	56,698
Cash flows from financing activities:
Net change in line of credit	(25,017)	33,040
Proceeds from convertible notes	1,150,000	0
Convertible notes deferred financing costs	(195,873)	0
Proceeds from long-term debt	0	25,080
Repayments of long-term debt	(8,259)	(7,602)
Net cash provided by financing activities	5,425,851	3,120,518
Effect of exchange rate on cash	50,487	(7,801)
Net change in cash	286,792	(1,012)
Cash - beginning of period	39,195	40,207
Cash - end of period	325,987	39,195
Promissory Notes [Member]
Cash flows from financing activities:
Proceeds from promissory notes	0	700,000
Repayments of promissory notes	(200,000)	0
Proceeds from notes	701,973	1,205,000
Convertible Notes [Member]
Cash flows from financing activities:
Proceeds from notes	3,500,000	0
Advances [Member]
Cash flows from financing activities:
Net increases of advances	$ 503,027	$ 1,165,000

Consolidated Statements of Stoc

Consolidated Statements of Stockholders' Deficit - USD ($)	Total	Common Stock	Additional Paid in Capital	Accumulated Other Comprehensive Loss	Accumulated Deficit
Balance at Dec. 31, 2014	$ (3,147,765)	$ 698	$ 6,176,865		$ (9,325,328)
Balance (in shares) at Dec. 31, 2014		6,975,000
Issuance of warrants in connection with investment advisory agreement	139,359	$ 0	139,359
Reverse business combination with Swift Start	10,500	$ 52	10,448
Reverse business combination with Swift Start (in shares)		525,000
Conversion of promissory notes	1,549,572	$ 44	1,549,528
Conversion of promissory notes (in shares)		442,735
Conversion of senior promissory notes	829,418	$ 24	829,394
Conversion of senior promissory notes (in shares)		236,977
Share-based professional services compensation	175,000	$ 5	174,995
Share-based professional services compensation (in shares)		50,000
Foreign currency translation adjustment	(7,801)			(7,801)
Net loss	(5,001,452)				(5,001,452)
Balance at Dec. 31, 2015	(5,453,169)	$ 823	8,880,589	(7,801)	(14,326,780)
Balance (in shares) at Dec. 31, 2015		8,229,712
Share-based employee and director compensation	674,782	$ 0	674,782
Share-based professional services compensation	48,953	0	48,953
Foreign currency translation adjustment	16,720			16,720
Net loss	(6,745,386)				(6,745,386)
Balance at Dec. 31, 2016	$ (11,458,100)	$ 823	$ 9,604,324	$ 8,919	$ (21,072,166)
Balance (in shares) at Dec. 31, 2016		8,229,712

Basis of Presentation and Going

Basis of Presentation and Going Concern	12 Months Ended
	Dec. 31, 2016
Basis Of Presentation And Going Concern [Abstract]
Basis Of Presentation And Going Concern Disclosure [Text Block]	Note 1. Basis of Presentation and Going Concern Nature of Operations -BioHiTech Global, Inc. (the “Company” or “BioHiTech”) through its wholly-owned subsidiaries, BioHiTech America, LLC, BioHiTech Europe Limited and E.N.A. Renewables LLC (formerly Entsorga North America, LLC), (collectively “subsidiaries”) offers its customers cost-effective and technologically innovative advancements integrating technological, biological and mechanical engineering solutions for the control, reduction and / or reuse of organic and municipal waste. Basis of Presentation - The accompanying consolidated financial statements include the accounts of the Company and its subsidiaries and have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”). All intercompany transactions have been eliminated in consolidation. Under ASC 280, Segment Reporting, the Company reports as a single segment company. On January 20, 2016 the Company formed a wholly owned subsidiary, Entsorga North America, LLC (“ENA”). On February 29, 2016, through an amended limited liability agreement, ENA became a 31 20.9 51.9 The accounts of business acquisitions are included in the consolidated financial statements from the dates of acquisition. Reclassifications to certain prior period amounts have been made to conform to current period presentation. These reclassifications have no effect on previously reported net loss. Going Concern - For the year ended December 31, 2016, the Company had a net loss of $ 6,745,386 5,924,667 5,181,400 11,458,100 5,096,220 The accompanying consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. These consolidated financial statements do not include any adjustments relating to the recovery of the recorded assets or the classification of the liabilities that might be necessary should the Company be unable to continue as a going concern. The ability of the Company to continue as a going concern is dependent on management's further implementation of the Company’s on-going and strategic plans, which include continuing to raise funds through debt and/or equity raises. Should the Company be unable to raise adequate funds, certain aspects of the on-going and strategic plans may require modification. The Company is presently in the process of raising additional non-registered convertible debt and capital for general operations, as well as for investment in several strategic initiatives. There is no assurance that the Company will be able to raise sufficient debt or capital to sustain operations or to pursue other strategic initiatives.

Summary of Significant Accounti

Summary of Significant Accounting Policies	12 Months Ended
	Dec. 31, 2016
Accounting Policies [Abstract]
Significant Accounting Policies [Text Block]	Note 2. Summary of Significant Accounting Policies — The preparation of consolidated financial statements, in conformity with GAAP requires the extensive use of management’s estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from these estimates. Estimates are used when accounting for items and matters including, but not limited to, allowance for uncollectible accounts receivable, obsolete, slow moving and excess inventory, asset valuations, including goodwill and intangibles, and useful lives, employee benefits, taxes and other provisions and contingencies. — Assets and liabilities denominated in foreign currencies are translated into U.S. dollars at the exchange rates existing at the respective balance sheet dates. Income and expense items are translated at the average rates during the respective periods. Translation adjustments resulting from fluctuations in exchange rates are recorded as a separate component of other comprehensive income (loss) while transaction gains and losses are recorded in net earnings (loss). Deferred taxes are not provided on cumulative foreign currency translation adjustments as the Company presently expects foreign earnings to be permanently reinvested. The Company pays Value Added Tax (“VAT”) or similar taxes (“input VAT”) within the normal course of its business in in the United Kingdom on merchandise and/or services it acquires. The Company also collects VAT or similar taxes on behalf of the government (“output VAT”) for merchandise and/or services it sells. If the output VAT exceeds the input VAT, then the difference is remitted to the government, usually on a monthly basis. If the input VAT exceeds the output VAT, this creates a VAT receivable. The Company either requests a refund of this VAT receivable or applies the balance to expected future VAT payables. — The Company recognizes revenue for the majority of its products sold upon transfer of title and the passage of the risk of ownership, which is generally upon shipment to the customer. Revenue from services is recognized as services are performed. The Company recognizes revenue from multiple-element arrangements when (i) persuasive evidence of an arrangement exists, (ii) delivery has occurred, (iii) the fee is fixed or determinable, and (iv) collectability of the sale is reasonably assured. The Company’s arrangements do not contain general rights of return. Deferred revenue represents amounts billed to customers or payments received from customers prior to providing services and for which the related revenue recognition criteria have not been met. The Company records taxes collected from customers and remitted to governmental authorities on a net basis. — The Company recognizes revenue from the rental of the digester units ratably on a monthly basis over the term of the lease, as it has determined that the rental agreements entered into in connection with its Eco Safe Digester units qualify as operating leases, for which the Company is the operating lessor. In order to determine lease classification as operating, the Company evaluates the terms of the rental agreement to determine if the lease includes any of the following provisions which would indicate sales type lease treatment: ⋅ Transfer of ownership of the digester unit, ⋅ Bargain purchase option at the end of the term of the lease, ⋅ Lease term is greater than 75% of the economic life of the digester unit, or ⋅ Present value of minimum lease payments exceed 90% of the fair value of the digester unit at inception of the lease. In addition, the Company also considers the following: ⋅ Collectability of the minimum lease payments is reasonably predictable, and ⋅ No important uncertainties surround the amount of unreimbursable costs yet to be incurred by the Company under the lease. Receivables and notes are stated net of allowances for doubtful accounts and primarily include trade receivables, notes receivable and miscellaneous receivables. Specific customer provisions are made when a review of significant outstanding amounts, utilizing information about customer creditworthiness and current economic trends, indicates that collection is doubtful. In addition, provisions are made at differing rates, based upon the age of the receivable and the Company’s historical collection experience. Inventory include parts, assemblies and finished equipment, which are stated at the lower of cost, based on the First-In, First-Out (FIFO) or specific identification methods or market, net of excess and slow moving reserves. Provisions for excess and obsolete inventories are made at differing rates, utilizing historical data and current economic trends, based upon the age and type of the inventory. Equipment, fixtures and vehicles, including equipment leased to others, is stated at cost less accumulated depreciation and amortization. Years Equipment leased to others 5 - 7 Computer software and hardware 3 - 5 Vehicles 5 Furniture and fixtures 7 - 15 The Company assesses potential impairments to its long-lived assets if events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Indefinite-lived intangible assets are reviewed annually for impairment, or more frequently if events or changes in circumstances indicate that the carrying value may not be recoverable. An impaired asset is written down to its estimated fair value based upon the most recent information available. Estimated fair market value is generally measured by discounting estimated future cash flows. Goodwill is reviewed for impairment annually or more frequently if events or changes in circumstances indicate that it is more likely than not that the fair value of a reporting unit is below its carrying value. The Company may perform a qualitative and quantitative assessments to determine if it is more likely than not that the fair value is less than its carrying amount.. In performing qualitative analysis, the Company considers various factors, including the excess of prior year estimates of fair value compared to carrying value, the effect of market or industry changes and the actual results compared to projected results. Based on this qualitative analysis, if management determines that it is more likely than not that the fair value of the reporting unit is greater than its carrying value, no further impairment testing is performed. In performing quantitative analysis, the Company considers comparable market valuations and expected future discounted cash flows to be generated. If the carrying value exceeds the fair value, the Company performs an additional fair value measurement calculation to determine the impairment loss, which is charged to operations in the period identified. Certain costs to acquire and develop computer software are capitalized and amortized over their estimated useful life using the straight-line method, up to a maximum of five years. Other intangible assets, except for those intangible assets with indefinite lives, are recognized separately from goodwill and are amortized over their estimated useful lives. Shipping and handling charges are recorded gross in both the revenue and in cost of revenue and amounted to $ 45,973 35,341 The Company expenses advertising costs as incurred. Advertising expense amounted to $ 61,489 22,218 All research and development costs incurred by the Company are expensed as incurred. — Certain assets and liabilities are required to be recorded at fair value on a recurring basis. Fair value is determined based on the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants. Assets measured at fair value on a nonrecurring basis include long-lived assets held and used, long-lived assets held for sale, goodwill and other intangible assets. The fair value of cash and cash equivalents, accounts receivable, short-term debt and accounts payable approximate their carrying values. The three-tier value hierarchy, which prioritizes valuation methodologies based on the reliability of the inputs, is: Level 1 — Valuations based on quoted prices for identical assets and liabilities in active markets. Level 2 — Valuations based on observable inputs other than quoted prices included in Level 1, such as quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets and liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data. Level 3 — Valuations based on unobservable inputs reflecting the Company’s own assumptions, consistent with reasonably available assumptions made by other market participants. The Company had no financial instruments measured at fair value on a recurring basis as of December 31, 2016 and 2015. During 2015, a warrant was issued with a fair value of $ 139,359 A goodwill impairment amount of $ 10,482 Deferred financing costs relating to issued debt are included as a reduction to the applicable debt and amortized as interest expense over the term of the related debt instruments. The Company reviews its convertible instruments for the existence of embedded conversion features that may require bifurcation. If certain criteria are met, the bifurcated derivative financial instrument is required to be recorded at fair value and adjusted to market at each reporting period end date. The Company also reviews and re-assesses, at each reporting date, any common stock purchase warrants and other freestanding derivative financial instruments and classifies them on the consolidated balance sheet as equity, assets or liabilities based upon the nature of the instruments. Comprehensive income (loss) for the Company consists of net earnings (loss) and foreign currency translation. Deferred income taxes are determined based on the estimated future tax effects of differences between the financial statement and tax bases of assets and liabilities given provisions of enacted laws. Deferred income tax provisions and benefits are based on changes to the asset or liabilities from year to year. In providing for deferred taxes, the Company considers tax regulations of the jurisdictions in which it operates, estimates the future taxable income and available tax planning strategies. If tax regulations, operating results or the ability to implement tax planning and strategies vary, adjustments to the carrying value of deferred tax assets and liabilities may be required. Valuation allowances are recorded related to deferred tax assets based on the “more than likely” criteria. The Company recognizes the financial statement benefit of a tax position only after determining that the relevant tax authority would more likely than not sustain the position following an audit. For tax positions meeting the more likely than not threshold, the amount recognized in the financial statements is the largest benefit that has a greater than 50 percent likelihood of being realized upon ultimate settlement with the relevant tax authority. As a result of the Swift Start Reverse Merger (Note 3), the Company’s results of operations are taxed as a C Corporation. Prior to the merger, the Company’s operations were taxed as a limited liability company, whereby the Company elected to be taxed as a partnership and income or loss was required to be reported by each respective member on their separate income tax returns. Therefore, no provision for income taxes has been provided in the accompanying financial statements for periods prior to August 6, 2015. The Company accounts for stock-based compensation in accordance with ASC 718, “Compensation - Stock Compensation.” ASC 718 requires generally that all equity awards be accounted for at their “fair value.” This fair value is measured on the grant date for stock-settled awards. Fair value is equal to the underlying value of the stock for “full-value” awards such as restricted stock and performance shares, and is estimated using an option-pricing model with traditional inputs for “appreciation” awards such as stock options and stock appreciation rights. Costs equal to these fair values are recognized as expense ratably over the requisite service period based on the number of awards that are expected to vest, or in the period of the grant for awards that vest immediately and have no future service condition. For awards that vest over time, cumulative adjustments in later periods are recorded to the extent actual forfeitures differ from the Company’s initial estimates; previously recognized compensation cost is reversed if the service or performance conditions are not satisfied and the award is forfeited. The expense resulting from share-based payments is recorded in the accompanying consolidated statements of operations based upon the classification of the underlying employees or service providers with a corresponding increase to additional paid in capital. Subsequent modifications to outstanding awards result in incremental cost if the fair value is increased as a result of the modification. Thus, a value-for-value stock option repricing or exchange of awards in conjunction with an equity restructuring does not result in additional compensation cost. The Company computes basic loss per share using the weighted-average number of shares of common stock outstanding and diluted loss per share, while the diluted loss per share also includes the effects of dilutive instruments using the “treasury method.” The Company’s potential dilutive instruments include options, convertible debt and warrants. These instruments have not been considered in the calculation of diluted loss per share as they are anti-dilutive for the reported periods.

Acquisitions and Disposals

Acquisitions and Disposals	12 Months Ended
	Dec. 31, 2016
Business Combinations [Abstract]
Mergers, Acquisitions and Dispositions Disclosures [Text Block]	Note 3. Acquisitions and Disposals Swift Start Reverse Merger - 6,975,000 0.0001 8,515,000 6,975,000 8,515,000 7,500,000 93 200,000,000 30,000,000 20,000,000 0.0001 10,000,000 0.0001 The Merger was accounted for as a reverse business combination. Under this method of accounting, the Company was treated as the acquiring company for financial reporting purposes. The net liabilities of Swift Start are stated at fair value, while the assets and liabilities of the Company are recognized at their historical basis. Pursuant to the reverse business combination, the Company has restated its consolidated statements of stockholders’ deficiency on a recapitalization basis, so that all accounts are now presented as if the reverse business combination had occurred at the beginning of the earliest period presented. The operating results for Swift Start are included in the consolidated financial statements from the effective date of the reverse business combination of August 6, 2015 and do not have a material impact on the financial statements. The $ 10,500 18 10,482 Sale of QTags Operations - On May 29, 2015, the Company consummated the sale of its QTags operations to CBI Mobile (Bahamas) Ltd. (“CBI Mobile”) for an aggregate sales price of $ 290,000 75,000 215,000 9.5 15 52,043 110,011

Accounts and Note Receivable, n

Accounts and Note Receivable, net	12 Months Ended
	Dec. 31, 2016
Receivables [Abstract]
Loans, Notes, Trade and Other Receivables Disclosure [Text Block]	Note 4. Accounts and Note Receivable, net December 31, 2016 2015 Accounts receivable $ 206,219 $ 271,862 Note receivable (Note 3) 52,043 110,011 Less: allowance for doubtful accounts and note receivable (118,132) (65,574) $ 140,130 $ 316,299 Year Ended December 31, 2016 2015 Balance at beginning of year $ 65,574 $ 72,179 Provision for doubtful accounts 93,406 39,247 Amounts written off (40,848) (45,852) Balance at end of year $ 118,132 $ 65,574

Inventory

Inventory	12 Months Ended
	Dec. 31, 2016
Inventory Disclosure [Abstract]
Inventory Disclosure [Text Block]	Note 5. Inventory December 31, 2016 2015 Equipment $ 191,240 $ 194,791 Parts and assemblies 514,777 79,513 $ 706,017 $ 274,304

Equipment on Operating Leases,

Equipment on Operating Leases, net	12 Months Ended
	Dec. 31, 2016
Equipment on Operating leases [Abstract]
Capital Leases in Financial Statements of Lessor Disclosure [Text Block]	Note 6. Equipment on Operating Leases, net Equipment on operating leases consist of the following: December 31, 2016 2015 Leased equipment $ 1,870,569 $ 1,601,005 Less: accumulated depreciation (847,165) (756,511) $ 1,023,404 $ 844,494 During the years ended December 31, 2016 and 2015, depreciation expense included in cost of revenue, amounted to $ 343,628 218,676 The Company is a lessor of Eco Safe digester units under non-cancellable operating lease agreements expiring through December 2021. During the years ended December 31, 2016 and 2015, revenue under the agreements, which is included in rental, service and parts revenue, amounted to $ 697,965 504,950 The minimum future estimated contractual payments to be received under these leases as of December 31, 2016 is as follows: Year Ending December 31, 2017 $ 693,361 2018 557,107 2019 391,611 2020 243,483 2021 and thereafter 77,362 Total minimum lease income $ 1,962,924

Equipment, Fixtures and Vehicle

Equipment, Fixtures and Vehicles, net	12 Months Ended
	Dec. 31, 2016
Property, Plant and Equipment [Abstract]
Property, Plant and Equipment Disclosure [Text Block]	Note 7. Equipment, Fixtures and Vehicles, net December 31, 2016 2015 Computer software and hardware $ 93,543 $ 85,397 Furniture and fixtures 48,196 48,196 Vehicles 69,253 69,253 210,992 202,846 Less: accumulated depreciation and amortization (156,636) (141,158) $ 54,356 $ 61,688 During the years ended December 31, 2016 and 2015, depreciation expense amounted to $ 15,478 24,290

Intangibles Assets, net

Intangibles Assets, net	12 Months Ended
	Dec. 31, 2016
Goodwill and Intangible Assets Disclosure [Abstract]
Intangible Assets Disclosure [Text Block]	Note 8. Intangibles Assets, net Remaining Useful Weighted Gross Lives Average Carrying Accumulated Net Carrying (Years) Life (Years) Amount Amortization Amount December 31, 2016: Distribution agreements 10 2.8 $ 902,000 $ (637,667) $ 264,333 Website 3 0.3 23,388 (20,679) 2,709 Intangible assets, net $ 925,388 $ (658,346) $ 267,042 December 31, 2015: Distribution agreements 10 3.8 $ 902,000 $ (547,467) $ 354,533 Website 3 1.3 23,388 (12,883) 10,505 Intangible assets, net $ 925,388 $ (560,350) $ 365,038 During the years ended December 31, 2016 and 2015, amortization expense, included in depreciation and amortization of operating expenses, amounted to $ 97,996 117,302 Year Ending December 31, 2017 92,909 2018 90,200 2019 43,533 2020 20,200 2021 20,200 Total $ 267,042

Risk Concentrations

Risk Concentrations	12 Months Ended
	Dec. 31, 2016
Risks and Uncertainties [Abstract]
Concentration Risk Disclosure [Text Block]	Note 9. Risk Concentrations The Company operates as a single segment on a worldwide basis though its subsidiaries, resellers and independent sales agents. United States International Total 2016: Revenue, for the year ended December 31, 2016 $ 1,681,490 $ 561,976 $ 2,243,466 Non-current tangible assets, as of December 31, 2016 1,019,664 71,596 1,091,260 2015: Revenue, for the year ended December 31,2015 $ 1,398,640 $ 115,341 $ 1,513,981 Non-current tangible assets, as of December 31, 2015 940,336 17,446 957,782 Credit risk - Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and accounts receivable. The Company minimizes credit risk associated with cash by periodically evaluating the credit quality of its primary financial institutions. At times, the Company’s cash may be uninsured or in deposit accounts that exceed the Federal Deposit Insurance Corporation (“FDIC”) in the USA and the Financial Conduct Authority (“FCA”) in the UK insurance limits. During the years ended December 31, 2016 and 2015, the Company had not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts. Major customers - During the year ended December 31, 2016, no customers represented at least 10 10 13 As of December 31, 2016 two customers represented at least 10 22 10 10 17 15 11 10 Vendor concentration - During the year ended December 31, 2016, two vendors represented at least 10 32 10 1.9 10 63 11 As of December 31, 2016, two vendors represented at least 10 32 1.9 21 10 37 12

Related Party Transactions

Related Party Transactions	12 Months Ended
	Dec. 31, 2016
Related Party Transactions [Abstract]
Related Party Transactions Disclosure [Text Block]	Note 10. Related Party Transactions Related parties include Directors, Senior Management Officers, and shareholders, plus their immediate family, who own a 5 December 31, 2016 2015 Assets: Intangible assets, net (a) $ 264,333 $ 354,533 Liabilities: Accounts payable 85,374 470,490 Accrued interest payable 390,812 275,517 Long term accrued interest 187,667 - Notes payable 275,000 300,000 Advance from related party (b) 1,213,027 710,000 Promissory note - related parties (c) 2,500,000 1,710,000 Series A - Unsecured subordinated convertible notes (d) 2,250,000 - Series B - Unsecured subordinated convertible notes (e) 1,250,000 - Series V - Unsecured subordinated convertible notes (f) 300,000 - Other: Line of credit guarantee (g) 2,463,736 2,488,753 The table below presents direct related party expenses or transactions for the periods indicated. Compensation and related costs for employees of the Company are excluded from the table below. Year Ended December 31 2016 2015 S, G & A - Rent expense (h) $ 52,657 $ 67,225 Cost of revenues - Rent expense (h) 42,773 - S, G & A - Consulting expense (a) 200,000 200,000 Interest expense 572,345 339,363 Cost of revenue, inventory or equipment on operating leases acquired (a and i) 1,355,780 633,819 There were no revenues earned from related parties during the years ended December 31, 2016 and 2015. (a) Distribution Agreement - BioHiTech has an exclusive license and distribution agreement (the “License Agreement”) with BioHiTech International (“BHT-I”), a company owned by Chun-Il Koh, a BioHiTech shareholder and other unrelated parties. The License Agreement provides distribution rights to the Eco-Safe Digester through December 31, 2023 (unless extended by mutual agreement) and for annual payments to Mr. Koh in the amount of $ 200,000 2.5 (b) Advance from Related Party - The Company’s Chief Executive Officer has advanced the Company funds for operating and capital purposes. The advances bear interest at 13 (c) Promissory Note - Related Party - On June 25, 2014, the Company initially entered into a secured promissory note with the Company’s Chief Executive Officer in the aggregate amount of $ 1,000,000 2,500,000 13 6,000,000 5,000,000 263,027 (d) Series A Unsecured Subordinated Convertible Notes and Warrants - In connection with the Company’s issuance of unsecured subordinated convertible notes and warrants in 2016, as further disclosed in Note 11, certain related parties participated in such offering. (e) Series B Unsecured Subordinated Convertible Notes and Warrants - In connection with the Company’s issuance of unsecured subordinated convertible notes and warrants in 2016, as further disclosed in Note 11, certain related parties participated in such offering. (f) Series V Unsecured Subordinated Convertible Notes – In connection with the Company’s issuance of 300,000 300,000 (g) Line of Credit - Under the terms of the line of credit, several related parties have personally guaranteed the line and are contingently liable should the Company not meet its obligations under the line. (h) Facility Lease - The Company leases its corporate headquarters and warehouse space from BioHiTech Realty LLC, a company owned by two stockholders of the Company, one of whom is the Chief Executive Officer. The lease expires in 2020, with a renewal option for an additional five-year period. Year Ending December 31, 2017 $ 97,066 2018 98,524 2019 100,003 2020 41,926 Total $ 337,519 (i) Inventory Acquisition – During 2016 the Company commenced acquiring certain sub-assemblies for final assembly by the Company from a company controlled by a 1.9

Line of Credit, Notes Payable,

Line of Credit, Notes Payable, Advance, Promissory Note, Convertible Promissory Notes and Long Term Debt	12 Months Ended
	Dec. 31, 2016
Debt Disclosure [Abstract]
Debt Disclosure [Text Block]	Note 11. Line of Credit, Notes Payable, Advance, Promissory Note, Convertible Promissory Notes and Long Term Debt December 31, 2016 December 31, 2015 Related Related Total Party Total Party Line of credit $ 2,463,736 $ - $ 2,488,753 $ - Unsecured subordinated convertible notes: - - Series A 3,310,500 2,250,000 - - Series B 1,220,634 1,250,000 - - Series V 425,000 300,000 - - Promissory note - related party 2,500,000 2,500,000 1,710,000 1,710,000 Notes payable 375,000 275,000 400,000 300,000 Advances 1,213,027 1,213,027 710,000 710,000 Long term debt - other, current and long term portion 19,573 - 27,833 - Line of Credit 2,500,000 0.5 4.25 4.0 250,000 2,459,453 2,405,197 4.02 3.77 Series A Unsecured Subordinated Convertible Promissory Notes – During 2016, the Company entered into a series of Securities Purchase Agreements (the “Purchase Agreement”) with certain accredited investors (the “Investors”), pursuant to which the Company agreed to sell and the Investors agreed to purchase in a private placement offering (the “Private Placement”) units (the “Units”) in the aggregate offering amount of $ 3,400,000 2,250,000 Each Unit is comprised of a convertible promissory note and warrants to purchase shares of the Company’s common stock. Each note bears interest at the rate of 8 February 10, 2018 3.75 The warrants are exercisable for a period of five years into shares of common stock equal to the number of shares of common stock into which the notes are convertible at an exercise price equal to 120 The embedded conversion feature and warrants issued in the transaction are not indexed to the Company’s common stock. However, the embedded conversion feature and warrants did not meet the definition of a derivative and therefore such conversion feature was not bifurcated from the underlying note payable and the warrants were not recorded as a derivative liability. As of December 31, 2016, the balance of the outstanding notes amounted to $ 3,400,000 89,500 165,230 75,730 Series B Unsecured Subordinated Convertible Promissory Notes – During 2016, the Company entered into a series of Securities Purchase Agreements (the “Purchase Agreement”) with certain accredited investors (the “Investors”), who were also shareholders of the Company, pursuant to which the Company agreed to sell and the Investors agreed to purchase in a private placement offering (the “Private Placement”) units (the “Units”) in the aggregate offering amount of $ 1,250,000 Each Unit is comprised of a convertible promissory note and warrants to purchase shares of the Company’s common stock. Each note bears interest at the rate of 8 November 18, 2018 2.75 The warrants are exercisable for a period of five years into shares of common stock equal to the number of shares of common stock into which the notes are convertible at an exercise price equal to 120 The embedded conversion feature and warrants issued in the transaction are not indexed to the Company’s common stock. However, the embedded conversion feature and warrants did not meet the definition of a derivative and therefore such conversion feature was not bifurcated from the underlying note payable and the warrants were not recorded as a derivative liability. As of December 31, 2016, the balance of the outstanding notes amounted to $ 1,250,000 29,366 30,643 1,277 Series V Subordinated Convertible Promissory Note – During 2016, the Company entered into a series of convertible promissory notes. Each note bears interest at the rate of 8 February 10, 2018 3.75 Notes Payable - During the year ended December 31, 2015, the Company entered into two unsecured promissory notes, which do not contain any financial covenants. As of December 31, 2016, the notes each have a remaining balance outstanding of $100,000 and $275,000 with interest at the rate of 10.0% and mature in July and September 2017, respectively. Long Term Debt - Represents two loans collateralized by vehicles with interest ranging from 1.9 4.98 Maturities of Non-Current Promissory Note, Long Term Debt and Unsecured Subordinated Convertible Notes – as of December 31, 2016, excluding deferred finance costs, Non- Year Ending December 31, Amortizing Amortizing * Total 2017 $ 8,525 $ - $ 8,525 2018 5,410 7,575,000 7,580,410 2019 5,200 - 5,200 2020 438 - 438 Total $ 19,573 $ 7,575,000 $ 7,594,573 * Certain non-amortizing notes are subject to earlier maturities. The table above presents all non-amortizing notes at their time period maturity condition. Senior Convertible Promissory Notes — During the year ended December 31, 2015, the Company entered into senior convertible promissory notes in the totaling $800,000 (the “Senior Convertible Promissory Notes”) with interest at 9% per annum, which is recorded as a component of interest expense. The Senior Convertible Promissory Notes were due on the earlier of the two-year anniversary of the respective Senior Convertible Promissory Notes or the consummation of a Qualified Financing. The holders were issued a five-year warrant to purchase equity interests of the Company valued at 10% of the dollar amount of the Senior Convertible Promissory Notes. If a Qualified Financing (the first issuance of equity by the Company through which the Company receives gross proceeds of a minimum of $5,000,000 from one or more financial institutions or accredited investors) occurs prior to the expiration date of such warrants, then the exercise price of the warrants will be equal to 120% of the Closing Price. If a Qualified Financing does not occur prior to the expiration date of the warrants, then the warrants will be deemed null and void and will expire worthless. On October 27, 2015, all amounts outstanding under the Senior Convertible Promissory Notes, inclusive of $29,418 accrued interest, were converted into 236,977 shares of the Company’s common stock at a conversion price of $3.50 per share, which was mutually agreed to by the Company and the debt holders. Convertible Promissory Notes — During the years ended December 31, 2015 and 2014, the Company entered into convertible promissory notes of $500,000 and $900,000, respectively, totaling $1,400,000 (the “Convertible Promissory Note”) with interest at 13% per annum, which is recorded as a component of interest expense. The Convertible Promissory Notes were due on the earlier of (a) a change of control (as defined in the Convertible Promissory Note), (b) an event of default (as defined in the Convertible Promissory Note), or (c) the two-year anniversary of the Convertible Promissory Note. In the event that there is a Qualified Financing (the first issuance of equity by the Company through which the Company receives gross proceeds of a minimum of $4,000,000 from one or more financial institutions or accredited investors.) prior to the repayment of the Convertible Promissory Notes, the Convertible Promissory Notes would automatically be converted into equity interests of the Company on terms no less favorable to the lenders than the terms provided to the investors in connection with the Qualified Financing. On October 27, 2015, all amounts outstanding under the Convertible Promissory Notes, inclusive of accrued interest amounting to $149,572, were converted into 442,735 shares of the Company’s common stock at a conversion price of $3.50 per share, which was mutually agreed to by the Company the debt holders. Interest Expense - All interest on the Company’s various debts are recognized as interest expense in the accompanying consolidated financial statements.

Equity Transactions

Equity Transactions	12 Months Ended
	Dec. 31, 2016
Disclosure Text Block Supplement [Abstract]
Shareholders' Equity and Share-based Payments [Text Block]	Note 12. Equity Transactions The Company has had the following equity related transactions over the two years ended December 31, 2016: Swift Start Reverse Merger – In connection with the reverse merger with Swift Start (See Note 3), the equity accounts of the Company have been retroactively conformed to the present capital structure. Prior to the Swift Start transaction, the capital section of the primary company was comprised of two-classes of membership in a limited liability company structure. All classes converted into common stock on equal terms. Maxim Warrants - In connection with the issuance of the Series A Units described in Note 11, the Company agreed to issue warrants to Maxim Group LLC, the placement agent, that are exercisable into 10 3.75 5 The unsecured subordinated convertible promissory notes contain conversion features that are required to be measured when the contingency is resolved. The terms of the conversion feature in the notes, and hence the Maxim Warrants, do not permit the Company to compute the number of common shares that the note holders will receive upon conversion. Accordingly, the Company must wait until the contingent event occurs to compute the number of shares that may be issued pursuant to the warrants. Barksdale Warrants - In connection with an Offering of BHTA in October 2013 of Class B Common Interests BHTA agreed to issue Barksdale Global Holdings, LLC (“Barksdale”) warrants to purchase a number of Class B Common Interests of BHTA, as now converted into Common Stock of the Company. The warrants were subsequently issued on June 30, 2015, whereby Barksdale was issued a warrant to purchase up to $ 140,000 5.0 The Company estimated the fair value of the warrant on the measurement date to be $ 14,182 10,744 50.24 1.42 Other Warrants - In connection with prior debt offerings that have been converted into equity, warrants expiring between May and July of 2020 representing an $80,000 purchase equity interest remain outstanding. The warrants allow the holders to acquire up to $80,000 of the Company’s common stock at a price of 120% of the closing price of the Company’s first issuance of equity in one, or a series of related transactions, through which the Company receives gross process of $5,000,000 or more from one or more financial institutions or “accredited investors”. Issuance of Restricted Stock in Connection with Investor Relations Services Agreement – During 2015, the Company entered into a one-year investor relations consulting agreement, which was not renewed in 2016. In addition to monthly cash fees, the Company issued 50,000 shares of fully vested restricted common stock at a per share price of $3.50, the price at which the promissory notes converted at on October 27, 2015. Strategic Consulting Agreement – During 2016, the Company entered into a strategic consulting agreement for a twelve-month term, subject to a sixty-day termination option by either party, which was exercised by the Company resulting in a termination effective December 31, 2016. In addition to monthly cash fees, the agreement also included issuing Series V convertible debt in the amount of $25,000 per month. As of December 31, 2016, $125,000 of such Series V convertible debt was outstanding. Shareholder Information and Marketing Agreement – During 2016, the Company entered into a service agreement for an initial three-month term, subject to a termination option after the initial 30-day period. In addition to monthly cash fees, the Company will issue 8,000 shares of restricted common stock that will vest over the three-month period. The accompanying financial statements reflect the vesting of such shares based upon the daily closing prices of the Company’s common stock. Public Relations and Corporate Communications Agreement – During 2016, the Company entered into a service agreement for a twelve-month term. In addition to monthly cash fees, the Company will issue 15,000 shares of fully vested restricted common stock at a per share price of $2.40, which is reflected as an expense in the accompanying financial statements. The agreement also requires an additional 10,000 shares of fully vested restricted common stock be granted at the beginning of the second six-month period of the agreement, which will result in an expense at that time.

Equity Incentive Plans

Equity Incentive Plans	12 Months Ended
	Dec. 31, 2016
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]	Note 13. Equity Incentive Plans During 2015, the Company established the BioHiTech Global, Inc. 2015 Equity Incentive Plan, which is available to eligible employees, directors, consultants and advisors of the Company and its affiliates. The plan allows for the granting of incentive stock options, nonqualified stock options, reload options, stock appreciation rights, and restricted stock representing up to 750,000 371,250 347,500 38,750 Stock Options - The fair value of options is estimated on the date of grant using the Black-Scholes option pricing model. The valuation determined by the Black-Scholes pricing model is affected by the Company’s stock price as well as assumptions regarding a number of highly complex and subjective variables. These variables include, but are not limited to, expected stock price volatility over the term of the awards, and actual and projected employee stock option exercise behaviors. The risk free rate is based on the U.S. Treasury rate for the expected life at the time of grant, volatility is based on the average long-term implied volatilities of peer companies, the expected life is based on the estimated average of the life of options using the simplified method, and forfeitures are estimated on the date of grant based on certain historical data. The Company utilizes the simplified method to determine the expected life of its options due to insufficient exercise activity during recent years as a basis from which to estimate future exercise patterns. The expected dividend assumption is based on the Company’s history and expectation of dividend payouts. Forfeitures are required to be estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates. 371,250 Risk-free interest rate 1.3 - 1.5 % Expected dividend yield 0.00 % Expected volatility 28.8 - 30.3 % Expected term in years 5.0 - 6.0 The options vest over four years. During the year ended December 31, 2016, compensation expense related to the stock options amounted to $ 245,635 The weighted-average grant date fair value of options granted on March 1, 2016 was $ 520,210 263,895 2.1 Weighted Average Weighted Remaining Average Contractual Number of Exercise Life Aggregate Options Price (in Years) Intrinsic Value Outstanding - December 31, 2015 - - - - Granted 371,250 $ 3.75 9.17 - Exercised - - - - Forfeited or Canceled (7,500) 3.75 - - Outstanding – December 31, 2016 363,750 $ 3.75 9.17 $ - Exercisable – December 31, 2016 90,418 $ 3.75 9.17 $ - Weighted Average Number of Grant Date Options Fair Value Balance at December 31, 2015 - Granted 371,250 $ 3.75 Vested (90,418) (3.75) Forfeited or Canceled (7,500) (3.75) Balance at December 31, 2016 273,332 $ 3.75 Restricted Stock Units – On April 15, 2016, the Company granted 347,500 15,833 4.05 1,407,375 746,251 During the year ended December 31, 2016, compensation expense related to the RSUs amounted to $ 429,146 Total unrecognized compensation expense related to the unvested RSUs at December 31, 2016 amounts to $ 978,229 2.16 Number of Shares Unvested balance at December 31, 2015 - Granted 347,500 Vested (15,833) Forfeited or Canceled - Unvested balance at December 31, 2016 331,667

Income Taxes

Income Taxes	12 Months Ended
	Dec. 31, 2016
Income Tax Disclosure [Abstract]
Income Tax Disclosure [Text Block]	Note 14. Income Taxes Year Ended December 31, 2016 2015 US Federal: Deferred $ (1,932,456) $ (1,055,914) State and local: Deferred (681,025) (215,098) Non-US: Deferred (69,203) - Change in valuation allowance 2,682,684 1,271,012 Income tax provision $ - $ - Year Ended December 31, 2016 2015 U. S. Federal Statutory rate (34.0) % (34.0) % Non-U.S. losses 0.6 1.0 Losses incurred before change in corporate tax status - 14.3 Local taxes, net of benefit (6.8) (2.8) Other 0.4 - (39.8) (21.5) Change in valuation allowance 39.8 21.5 Effective income tax rate - % - % December 31, 2016 2015 Deferred tax assets: Net operating losses - Federal $ 2,341,288 $ 1,067,247 Net operating losses - State 691,582 217,765 Net operating losses - Non-US 69,203 - Stock-based compensation - Federal 246,069 - Stock-based compensation - State 77,440 - Accrued liabilities - Federal 412,346 - Accrued liabilities - State 129,768 - 3,967,696 1,285,012 Deferred tax liabilities: Property and equipment - Federal (11,333) (11,333) Property and equipment - State (2,667) (2,667) (14,000) (14,000) Net deferred tax assets 3,953,696 1,271,012 Valuation allowance (3,953,696) (1,271,012) Net deferred tax assets $ - $ - The net operating loss carryovers may be subject to limitation under Internal Revenue Code Section 382 should there be greater than a 50% ownership change as determined under the regulations. At December 31, 2016, the Company had net operating loss carryforwards for federal, state and non-US income tax purposes of approximately $ 7,198,649 December 31, 2035

Commitments and Contingencies

Commitments and Contingencies	12 Months Ended
	Dec. 31, 2016
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies Disclosure [Text Block]	Note 15. Commitments and Contingencies From time to time, the Company is involved in legal matters arising in the ordinary course of business. While the Company believes that such matters are currently not material, there can be no assurance that matters arising in the ordinary course of business for which the Company is, or could be, involved in litigation, will not have a material adverse effect on its business, financial condition or results of operations.

Employee 401(k) Savings Plan

Employee 401(k) Savings Plan	12 Months Ended
	Dec. 31, 2016
Employee 401K Saving Plan [Abstract]
Employee 401K Saving Plan [Text Block]	Note 16. Employee 401(k) Savings Plan During 2015 the Company established a defined contribution retirement savings plan qualified under Section 401(k) of the Internal Revenue Code, which became operative effective January 1, 2016. Under the plan, employees may contribute a percentage of eligible compensation on both a before-tax and after-tax basis. The Company may match a percentage of employee’s before-tax contributions, but is not required to do so, as the annual matching contributions are discretionary. No contributions have been made to the plan by the Company.

Operating Leases

Operating Leases	12 Months Ended
	Dec. 31, 2016
Leases, Operating [Abstract]
Operating Leases of Lessor Disclosure [Text Block]	Note 17. Operating Leases The Company rents its headquarters and attached warehousing space from a related party (see Note 10) and their research and development office from an unrelated party under operating leases. 2015 2018 Year Ending December 31, 2017 119,480 2018 115,710 2019 100,003 2020 41,926 Total $ 377,119 Total rent expense under all operating leases amounted to $ 128,903 105,925

Supplemental Consolidated State

Supplemental Consolidated Statement of Cash Flows Information	12 Months Ended
	Dec. 31, 2016
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION
Cash Flow, Supplemental Disclosures [Text Block]	Note 18. Supplemental Consolidated Statement of Cash Flows Information Year Ended December 31, 2016 2015 Changes in operating assets and liabilities: Accounts and note receivable $ 79,743 $ (62,225) Inventory (997,535) (271,171) Prepaid expenses and other assets 42,722 (47,602) Accounts payable 281,787 953,087 Accrued interest payable 640,056 373,608 Accrued expenses 12,800 493,461 Deferred revenue 16,360 653 Customer deposits 11,803 (4,789) Net change in operating assets and liabilities $ 87,736 $ 1,435,022 Supplementary cash flow information: Cash paid during the year for: Interest $ 106,251 $ 91,811 Income taxes - - Supplementary Disclosure of Non-Cash Investing and Financing Activities: Transfer of inventory to leased equipment $ 531,392 $ 233,900 Series V Notes issued in settlement of accounts payable with a related party 300,000 - Accrued interest added to principle of promissory note - related party 263,027 - Conversion of senior promissory notes and related accrued interest into common stock - 829,418 Warrants issued in connection with advisory services - 139,359 Goodwill recognized in connection with Swift Start acquisition - 10,482 Advances to vendors applied to inventory - 44,700 Conversion of promissory notes and related accrued interest into common stock - 1,549,572 Conversion of advances from related party to promissory note - 505,000

Recent Accounting Pronouncement

Recent Accounting Pronouncements	12 Months Ended
	Dec. 31, 2016
New Accounting Pronouncements and Changes in Accounting Principles [Abstract]
New Accounting Pronouncements and Changes in Accounting Principles [Text Block]	Note 19. Recent Accounting Pronouncements Statement of Cash Flows – In August 2016, the FASB issued Accounting Standards Update No. 2016-15, Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments Statement of Cash Flows statement of cash flows with the objective of reducing the existing diversity in practice related to eight specific cash flow issues. The amendments in this update are effective for annual periods beginning after December 15, 2017, and interim periods within those fiscal years. Early adoption is permitted. The Company does not expect the adoption of ASU 2016-15 to have a material impact on its consolidated financial statements. Revenue from Contracts with Customers - In April 2016, the FASB issued Accounting Standards Update (“ASU”) No. 2016-10, “Revenue from Contracts with Customers - Identifying Performance Obligations and Licensing” (Topic 606). The amendments clarify two aspects of ASU No. 2014-09, “Revenue from Contracts with Customers,” by providing (1) guidance for identifying performance obligations and (2) licensing implementation guidance. Public business entities should apply the guidance similar to Update 2014-09 to annual reporting periods beginning after December 15, 2017, including interim periods within that reporting period. Earlier application is permitted only as of annual reporting periods beginning after December 15, 2016, including interim reporting periods within that reporting period. In May 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) ASU No. 2014-09, “Revenue from Contracts with Customers” (ASU 2014-09). ASU 2014-09 provides guidance for revenue recognition and affects any entity that either enters into contracts with customers to transfer goods or services or enters into contracts for the transfer of nonfinancial assets and supersedes the revenue recognition requirements in Topic 605, “Revenue Recognition,” and most industry-specific guidance. The core principle of ASU 2014-09 is the recognition of revenue when a company transfers promised goods or services to customers in an amount that reflects the consideration to which the company expects to be entitled in exchange for those goods or services. ASU 2014-09 defines a five-step process to achieve this core principle and, in doing so, companies will need to use more judgment and make more estimates than under the current guidance. These may include identifying performance obligations in the contract, estimating the amount of variable consideration to include in the transaction price and allocating the transaction price to each separate performance obligation. ASU 2014-09, as amended, is effective for fiscal years beginning after December 15, 2017 and interim periods therein, using either of the following transition methods: (i) a full retrospective approach reflecting the application of the standard in each prior reporting period with the option to elect certain practical expedients, or (ii) a retrospective approach with the cumulative effect of initially adopting ASU 2014-09 recognized at the date of adoption (which includes additional footnote disclosures). The Company does not anticipate that the adoption, by means of a retrospective approach with a cumulative effect, if any, will have a material effect on its consolidated financial position or results of operations. Stock Compensation - In March 2016, FASB issued ASU No. 2016-09, “Compensation - Stock Compensation: Improvements to Employee Share-Based Payment Accounting” (Topic 718). The amendments in this ASU is to significantly reduce the complexity and cost of accounting for excess tax benefits and tax deficiencies related to employee share-based payment transactions, which include restricted stock and stock options. Also, ASU No. 2016-09 requires an entity to run excess tax benefits and deficiencies through its income statement, which in effect eliminates the concept of additional paid-in capital. For public business entities, the amendments in this ASU are effective for financial statements issued for annual periods beginning after December 15, 2016, including interim periods within those annual periods. The Company will evaluate the effects, if any, that adoption of this ASU will have on its consolidated financial position or results of operations. Leases - In February 2016, the FASB issued new lease accounting guidance (ASU No. 2016-02, Leases). Inventory - In July 2015, the FASB issued ASU No. 2015-11, “Inventory (Topic 330): Simplifying the Measurement of Inventory” (“ASU 2015-11”). ASU 2015-11 requires inventory measured using any method other than last-in, first out (“LIFO”) or the retail inventory method to be subsequently measured at the lower of cost or net realizable value, rather than at the lower of cost or market. This ASU is effective prospectively for fiscal years beginning after December 15, 2016 and their related interim periods. Early application is permitted. The Company does not anticipate that the adoption will have a material effect on its consolidated financial position or results of operations.

Subsequent Events

Subsequent Events	12 Months Ended
	Dec. 31, 2016
Subsequent Events [Abstract]
Subsequent Events [Text Block]	Note 20. Subsequent Events The Company evaluates subsequent events and transactions that occur after the balance sheet date up to the date that the financial statements are available to be issued. Any material events that occur between the balance sheet date and the date that the financial statements were available for issuance are disclosed as subsequent events, while the financial statements are adjusted to reflect any conditions that existed at the balance sheet date. Based upon this review, except as discussed below, the Company did not identify any recognized or non-recognized subsequent events that would have required adjustment or disclosure in the financial statements. Series B Unsecured Subordinated Convertible Promissory Notes – During January, February and March 2017, the Company closed on additional notes amounting to $ 625,000 500,000 Promissory Note and Advances – Related Party – Effective February 1, 2017, The Company entered into a Fourth Amended and Restated Secured Promissory Note that increased the available balance from $ 2,500,000 4,500,000 January 1, 2018 February 1, 2019 1,213,027 Authorized Common Shares – On January 25, 2017, the Company’s Board of Directors approved to increase the authorized number of common shares, $ 0.0001 20,000,000 50,000,000 2017 Executive Stock Incentive Plan – On January 25, 2017, the Company’s Board of Directors approved the 2017 Executive Equity Incentive Plan, which provides for a range of grants of up to 1,000,000 Entsorga West Virginia LLC (“EWV”) Investment – Effective January 1, 2017, the Company executed several agreements to acquire up to approximately a 40 60,000 1,034,028 17.2 23.1 1,034,028 17.2 EWV represents the first deployment of the Entsorga High Efficiency Biological Treatment (“HEBioT”) technology in the United States. Such deployment is currently underway in Martinsburg, WV. EWV has its own intellectual property agreement with Entsorgafin S.p.A. that is not part of the agreement that Apple Valley Waste Conversions, LLC has with Entsorgafin S.p.A. The EWV plant has received its necessary permits and EWV has closed on its financing to construct the facility and held its groundbreaking ceremony in January 2016, is currently under construction and is expected to begin commercial operations in the second half of 2017. The facility will be able to accept up to 110,000 tons per year of municipal solid waste delivered from the surrounding areas. Its facility will consist of a 54,000-square foot industrial building located on approximately 12 acres of leased property. The facility will include a plant which will be equipped with HEBioT technology and will ultimately be able to produce approximately 50,000 tons per year of EPA recognized renewable fuel. EWV and the facility are collateral to a financing through Tax Exempt Industrial Development Bonds issued by the West Virginia Economic Development Authority in the amount of $ 25,000,000 6,000,000 New York MBT Facility Site Acquisition – On March 1, 2017 the Town Board of the Town of New Windsor, NY approved an agreement that provides for the Company to acquire approximately 12 acres of land at Stewart International Airport for purposes of development of a mechanical biological treatment (MBT) plant utilizing the Company’s Entsorga technology for $ 1,092,000 3,500 6,000

Summary of Significant Accoun27

Summary of Significant Accounting Policies (Policies)	12 Months Ended
	Dec. 31, 2016
Accounting Policies [Abstract]
Use of Estimates, Policy [Policy Text Block]	Use of Estimates — The preparation of consolidated financial statements, in conformity with GAAP requires the extensive use of management’s estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from these estimates. Estimates are used when accounting for items and matters including, but not limited to, allowance for uncollectible accounts receivable, obsolete, slow moving and excess inventory, asset valuations, including goodwill and intangibles, and useful lives, employee benefits, taxes and other provisions and contingencies.
Foreign Currency Transactions and Translations Policy [Policy Text Block]	Foreign Operations — Assets and liabilities denominated in foreign currencies are translated into U.S. dollars at the exchange rates existing at the respective balance sheet dates. Income and expense items are translated at the average rates during the respective periods. Translation adjustments resulting from fluctuations in exchange rates are recorded as a separate component of other comprehensive income (loss) while transaction gains and losses are recorded in net earnings (loss). Deferred taxes are not provided on cumulative foreign currency translation adjustments as the Company presently expects foreign earnings to be permanently reinvested. The Company pays Value Added Tax (“VAT”) or similar taxes (“input VAT”) within the normal course of its business in in the United Kingdom on merchandise and/or services it acquires. The Company also collects VAT or similar taxes on behalf of the government (“output VAT”) for merchandise and/or services it sells. If the output VAT exceeds the input VAT, then the difference is remitted to the government, usually on a monthly basis. If the input VAT exceeds the output VAT, this creates a VAT receivable. The Company either requests a refund of this VAT receivable or applies the balance to expected future VAT payables.
Revenue Recognition, Policy [Policy Text Block]	Product and Services Revenue Recognition — The Company recognizes revenue for the majority of its products sold upon transfer of title and the passage of the risk of ownership, which is generally upon shipment to the customer. Revenue from services is recognized as services are performed. The Company recognizes revenue from multiple-element arrangements when (i) persuasive evidence of an arrangement exists, (ii) delivery has occurred, (iii) the fee is fixed or determinable, and (iv) collectability of the sale is reasonably assured. The Company’s arrangements do not contain general rights of return. Deferred revenue represents amounts billed to customers or payments received from customers prior to providing services and for which the related revenue recognition criteria have not been met. The Company records taxes collected from customers and remitted to governmental authorities on a net basis.
Revenue Recognition Leases [Policy Text Block]	Lease Revenue Recognition — The Company recognizes revenue from the rental of the digester units ratably on a monthly basis over the term of the lease, as it has determined that the rental agreements entered into in connection with its Eco Safe Digester units qualify as operating leases, for which the Company is the operating lessor. In order to determine lease classification as operating, the Company evaluates the terms of the rental agreement to determine if the lease includes any of the following provisions which would indicate sales type lease treatment: ⋅ Transfer of ownership of the digester unit, ⋅ Bargain purchase option at the end of the term of the lease, ⋅ Lease term is greater than 75% of the economic life of the digester unit, or ⋅ Present value of minimum lease payments exceed 90% of the fair value of the digester unit at inception of the lease. In addition, the Company also considers the following: ⋅ Collectability of the minimum lease payments is reasonably predictable, and ⋅ No important uncertainties surround the amount of unreimbursable costs yet to be incurred by the Company under the lease.
Receivables, Policy [Policy Text Block]	Accounts and Notes Receivable, net — Receivables and notes are stated net of allowances for doubtful accounts and primarily include trade receivables, notes receivable and miscellaneous receivables. Specific customer provisions are made when a review of significant outstanding amounts, utilizing information about customer creditworthiness and current economic trends, indicates that collection is doubtful. In addition, provisions are made at differing rates, based upon the age of the receivable and the Company’s historical collection experience.
Inventory, Policy [Policy Text Block]	Inventory — Inventory include parts, assemblies and finished equipment, which are stated at the lower of cost, based on the First-In, First-Out (FIFO) or specific identification methods or market, net of excess and slow moving reserves. Provisions for excess and obsolete inventories are made at differing rates, utilizing historical data and current economic trends, based upon the age and type of the inventory.
Property, Plant and Equipment, Policy [Policy Text Block]	Equipment, Fixtures and Vehicles, Including Equipment Leased to Others — Equipment, fixtures and vehicles, including equipment leased to others, is stated at cost less accumulated depreciation and amortization. Years Equipment leased to others 5 - 7 Computer software and hardware 3 - 5 Vehicles 5 Furniture and fixtures 7 - 15
Impairment or Disposal of Long-Lived Assets, Including Intangible Assets, Policy [Policy Text Block]	Long-Lived Assets — The Company assesses potential impairments to its long-lived assets if events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Indefinite-lived intangible assets are reviewed annually for impairment, or more frequently if events or changes in circumstances indicate that the carrying value may not be recoverable. An impaired asset is written down to its estimated fair value based upon the most recent information available. Estimated fair market value is generally measured by discounting estimated future cash flows.
Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]	Goodwill — Goodwill is reviewed for impairment annually or more frequently if events or changes in circumstances indicate that it is more likely than not that the fair value of a reporting unit is below its carrying value. The Company may perform a qualitative and quantitative assessments to determine if it is more likely than not that the fair value is less than its carrying amount.. In performing qualitative analysis, the Company considers various factors, including the excess of prior year estimates of fair value compared to carrying value, the effect of market or industry changes and the actual results compared to projected results. Based on this qualitative analysis, if management determines that it is more likely than not that the fair value of the reporting unit is greater than its carrying value, no further impairment testing is performed. In performing quantitative analysis, the Company considers comparable market valuations and expected future discounted cash flows to be generated. If the carrying value exceeds the fair value, the Company performs an additional fair value measurement calculation to determine the impairment loss, which is charged to operations in the period identified.
Depreciation, Depletion, and Amortization [Policy Text Block]	Amortization — Certain costs to acquire and develop computer software are capitalized and amortized over their estimated useful life using the straight-line method, up to a maximum of five years. Other intangible assets, except for those intangible assets with indefinite lives, are recognized separately from goodwill and are amortized over their estimated useful lives.
Shipping and Handling Cost, Policy [Policy Text Block]	Shipping Costs — Shipping and handling charges are recorded gross in both the revenue and in cost of revenue and amounted to $ 45,973 35,341
Advertising Costs, Policy [Policy Text Block]	Advertising — The Company expenses advertising costs as incurred. Advertising expense amounted to $ 61,489 22,218
Research and Development Expense, Policy [Policy Text Block]	Research and Development — All research and development costs incurred by the Company are expensed as incurred.
Fair Value Measurement, Policy [Policy Text Block]	Fair Value Measurements — Certain assets and liabilities are required to be recorded at fair value on a recurring basis. Fair value is determined based on the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants. Assets measured at fair value on a nonrecurring basis include long-lived assets held and used, long-lived assets held for sale, goodwill and other intangible assets. The fair value of cash and cash equivalents, accounts receivable, short-term debt and accounts payable approximate their carrying values. The three-tier value hierarchy, which prioritizes valuation methodologies based on the reliability of the inputs, is: Level 1 — Valuations based on quoted prices for identical assets and liabilities in active markets. Level 2 — Valuations based on observable inputs other than quoted prices included in Level 1, such as quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets and liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data. Level 3 — Valuations based on unobservable inputs reflecting the Company’s own assumptions, consistent with reasonably available assumptions made by other market participants. The Company had no financial instruments measured at fair value on a recurring basis as of December 31, 2016 and 2015. During 2015, a warrant was issued with a fair value of $ 139,359 A goodwill impairment amount of $ 10,482
Deferred Offering Costs [Text Block]	Deferred Financing Costs - Deferred financing costs relating to issued debt are included as a reduction to the applicable debt and amortized as interest expense over the term of the related debt instruments.
Fair Value of Financial Instruments, Policy [Policy Text Block]	Financial Instruments, Convertible Instruments, Warrants and Derivatives - The Company reviews its convertible instruments for the existence of embedded conversion features that may require bifurcation. If certain criteria are met, the bifurcated derivative financial instrument is required to be recorded at fair value and adjusted to market at each reporting period end date. The Company also reviews and re-assesses, at each reporting date, any common stock purchase warrants and other freestanding derivative financial instruments and classifies them on the consolidated balance sheet as equity, assets or liabilities based upon the nature of the instruments.
Comprehensive Income, Policy [Policy Text Block]	Comprehensive Income (Loss) - Comprehensive income (loss) for the Company consists of net earnings (loss) and foreign currency translation.
Income Tax, Policy [Policy Text Block]	Income Taxes - Deferred income taxes are determined based on the estimated future tax effects of differences between the financial statement and tax bases of assets and liabilities given provisions of enacted laws. Deferred income tax provisions and benefits are based on changes to the asset or liabilities from year to year. In providing for deferred taxes, the Company considers tax regulations of the jurisdictions in which it operates, estimates the future taxable income and available tax planning strategies. If tax regulations, operating results or the ability to implement tax planning and strategies vary, adjustments to the carrying value of deferred tax assets and liabilities may be required. Valuation allowances are recorded related to deferred tax assets based on the “more than likely” criteria. The Company recognizes the financial statement benefit of a tax position only after determining that the relevant tax authority would more likely than not sustain the position following an audit. For tax positions meeting the more likely than not threshold, the amount recognized in the financial statements is the largest benefit that has a greater than 50 percent likelihood of being realized upon ultimate settlement with the relevant tax authority. As a result of the Swift Start Reverse Merger (Note 3), the Company’s results of operations are taxed as a C Corporation. Prior to the merger, the Company’s operations were taxed as a limited liability company, whereby the Company elected to be taxed as a partnership and income or loss was required to be reported by each respective member on their separate income tax returns. Therefore, no provision for income taxes has been provided in the accompanying financial statements for periods prior to August 6, 2015.
Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block]	Stock-Based Compensation - The Company accounts for stock-based compensation in accordance with ASC 718, “Compensation - Stock Compensation.” ASC 718 requires generally that all equity awards be accounted for at their “fair value.” This fair value is measured on the grant date for stock-settled awards. Fair value is equal to the underlying value of the stock for “full-value” awards such as restricted stock and performance shares, and is estimated using an option-pricing model with traditional inputs for “appreciation” awards such as stock options and stock appreciation rights. Costs equal to these fair values are recognized as expense ratably over the requisite service period based on the number of awards that are expected to vest, or in the period of the grant for awards that vest immediately and have no future service condition. For awards that vest over time, cumulative adjustments in later periods are recorded to the extent actual forfeitures differ from the Company’s initial estimates; previously recognized compensation cost is reversed if the service or performance conditions are not satisfied and the award is forfeited. The expense resulting from share-based payments is recorded in the accompanying consolidated statements of operations based upon the classification of the underlying employees or service providers with a corresponding increase to additional paid in capital. Subsequent modifications to outstanding awards result in incremental cost if the fair value is increased as a result of the modification. Thus, a value-for-value stock option repricing or exchange of awards in conjunction with an equity restructuring does not result in additional compensation cost.
Earnings Per Share, Policy [Policy Text Block]	Loss per Share – The Company computes basic loss per share using the weighted-average number of shares of common stock outstanding and diluted loss per share, while the diluted loss per share also includes the effects of dilutive instruments using the “treasury method.” The Company’s potential dilutive instruments include options, convertible debt and warrants. These instruments have not been considered in the calculation of diluted loss per share as they are anti-dilutive for the reported periods.

Summary of Significant Accoun28

Summary of Significant Accounting Policies (Tables)	12 Months Ended
	Dec. 31, 2016
Accounting Policies [Abstract]
Property Plant and Equipment Useful life Disclosure [Table Text Block]	Depreciation is provided using the straight-line method over the estimated useful lives of the related assets, as follows: Years Equipment leased to others 5 - 7 Computer software and hardware 3 - 5 Vehicles 5 Furniture and fixtures 7 - 15

Accounts and Note Receivable,29

Accounts and Note Receivable, net (Tables)	12 Months Ended
	Dec. 31, 2016
Receivables [Abstract]
Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]	Accounts and note receivable consists of the following: December 31, 2016 2015 Accounts receivable $ 206,219 $ 271,862 Note receivable (Note 3) 52,043 110,011 Less: allowance for doubtful accounts and note receivable (118,132) (65,574) $ 140,130 $ 316,299
Allowance for Doubtful Account [Table Text Block]	Allowance for doubtful accounts activities are as follows: Year Ended December 31, 2016 2015 Balance at beginning of year $ 65,574 $ 72,179 Provision for doubtful accounts 93,406 39,247 Amounts written off (40,848) (45,852) Balance at end of year $ 118,132 $ 65,574

Inventory (Tables)

Inventory (Tables)	12 Months Ended
	Dec. 31, 2016
Inventory Disclosure [Abstract]
Schedule of Inventory, Current [Table Text Block]	Inventory, comprised of finished goods and parts or assemblies, consist of the following: December 31, 2016 2015 Equipment $ 191,240 $ 194,791 Parts and assemblies 514,777 79,513 $ 706,017 $ 274,304

Equipment on Operating Leases31

Equipment on Operating Leases, net (Tables)	12 Months Ended
	Dec. 31, 2016
Equipment on Operating Leases, Net [Abstract]
Schedule of Property Subject to or Available for Operating Lease [Table Text Block]	Equipment on operating leases consist of the following: December 31, 2016 2015 Leased equipment $ 1,870,569 $ 1,601,005 Less: accumulated depreciation (847,165) (756,511) $ 1,023,404 $ 844,494
Schedule Of Future Minimum Rental Payments Receivable For Operating Leases [Table Text Block]	The minimum future estimated contractual payments to be received under these leases as of December 31, 2016 is as follows: Year Ending December 31, 2017 $ 693,361 2018 557,107 2019 391,611 2020 243,483 2021 and thereafter 77,362 Total minimum lease income $ 1,962,924

Equipment, Fixtures and Vehic32

Equipment, Fixtures and Vehicles, net (Tables)	12 Months Ended
	Dec. 31, 2016
Property, Plant and Equipment [Abstract]
Property, Plant and Equipment [Table Text Block]	Equipment, fixtures and vehicles consist of the following: December 31, 2016 2015 Computer software and hardware $ 93,543 $ 85,397 Furniture and fixtures 48,196 48,196 Vehicles 69,253 69,253 210,992 202,846 Less: accumulated depreciation and amortization (156,636) (141,158) $ 54,356 $ 61,688

Intangibles Assets, net (Tables

Intangibles Assets, net (Tables)	12 Months Ended
	Dec. 31, 2016
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Intangible Assets and Goodwill [Table Text Block]	Intangible assets consist of the following: Remaining Useful Weighted Gross Lives Average Carrying Accumulated Net Carrying (Years) Life (Years) Amount Amortization Amount December 31, 2016: Distribution agreements 10 2.8 $ 902,000 $ (637,667) $ 264,333 Website 3 0.3 23,388 (20,679) 2,709 Intangible assets, net $ 925,388 $ (658,346) $ 267,042 December 31, 2015: Distribution agreements 10 3.8 $ 902,000 $ (547,467) $ 354,533 Website 3 1.3 23,388 (12,883) 10,505 Intangible assets, net $ 925,388 $ (560,350) $ 365,038
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]	At December 31, 2016, future annual estimated amortization expense is summarized as follows: Year Ending December 31, 2017 92,909 2018 90,200 2019 43,533 2020 20,200 2021 20,200 Total $ 267,042

Risk Concentrations (Tables)

Risk Concentrations (Tables)	12 Months Ended
	Dec. 31, 2016
Risks and Uncertainties [Abstract]
Revenue from External Customers by Geographic Areas [Table Text Block]	Gross revenues and net non-current tangible assets on a domestic and international basis is as follows: United States International Total 2016: Revenue, for the year ended December 31, 2016 $ 1,681,490 $ 561,976 $ 2,243,466 Non-current tangible assets, as of December 31, 2016 1,019,664 71,596 1,091,260 2015: Revenue, for the year ended December 31,2015 $ 1,398,640 $ 115,341 $ 1,513,981 Non-current tangible assets, as of December 31, 2015 940,336 17,446 957,782

Related Party Transactions (Tab

Related Party Transactions (Tables)	12 Months Ended
	Dec. 31, 2016
Schedule of Related Party Transactions [Table Text Block]	December 31, 2016 2015 Assets: Intangible assets, net (a) $ 264,333 $ 354,533 Liabilities: Accounts payable 85,374 470,490 Accrued interest payable 390,812 275,517 Long term accrued interest 187,667 - Notes payable 275,000 300,000 Advance from related party (b) 1,213,027 710,000 Promissory note - related parties (c) 2,500,000 1,710,000 Series A - Unsecured subordinated convertible notes (d) 2,250,000 - Series B - Unsecured subordinated convertible notes (e) 1,250,000 - Series V - Unsecured subordinated convertible notes (f) 300,000 - Other: Line of credit guarantee (g) 2,463,736 2,488,753 The table below presents direct related party expenses or transactions for the periods indicated. Compensation and related costs for employees of the Company are excluded from the table below. Year Ended December 31 2016 2015 S, G & A - Rent expense (h) $ 52,657 $ 67,225 Cost of revenues - Rent expense (h) 42,773 - S, G & A - Consulting expense (a) 200,000 200,000 Interest expense 572,345 339,363 Cost of revenue, inventory or equipment on operating leases acquired (a and i) 1,355,780 633,819 There were no revenues earned from related parties during the years ended December 31, 2016 and 2015. (a) Distribution Agreement - BioHiTech has an exclusive license and distribution agreement (the “License Agreement”) with BioHiTech International (“BHT-I”), a company owned by Chun-Il Koh, a BioHiTech shareholder and other unrelated parties. The License Agreement provides distribution rights to the Eco-Safe Digester through December 31, 2023 (unless extended by mutual agreement) and for annual payments to Mr. Koh in the amount of $ 200,000 2.5 (b) Advance from Related Party - The Company’s Chief Executive Officer has advanced the Company funds for operating and capital purposes. The advances bear interest at 13 (c) Promissory Note - Related Party - On June 25, 2014, the Company initially entered into a secured promissory note with the Company’s Chief Executive Officer in the aggregate amount of $ 1,000,000 2,500,000 13 6,000,000 5,000,000 263,027 (d) Series A Unsecured Subordinated Convertible Notes and Warrants - In connection with the Company’s issuance of unsecured subordinated convertible notes and warrants in 2016, as further disclosed in Note 11, certain related parties participated in such offering. (e) Series B Unsecured Subordinated Convertible Notes and Warrants - In connection with the Company’s issuance of unsecured subordinated convertible notes and warrants in 2016, as further disclosed in Note 11, certain related parties participated in such offering. (f) Series V Unsecured Subordinated Convertible Notes – In connection with the Company’s issuance of 300,000 300,000 (g) Line of Credit - Under the terms of the line of credit, several related parties have personally guaranteed the line and are contingently liable should the Company not meet its obligations under the line. (h) Facility Lease - The Company leases its corporate headquarters and warehouse space from BioHiTech Realty LLC, a company owned by two stockholders of the Company, one of whom is the Chief Executive Officer. The lease expires in 2020, with a renewal option for an additional five-year period. (i) Inventory Acquisition – During 2016 the Company commenced acquiring certain sub-assemblies for final assembly by the Company from a company controlled by a 1.9
Facility Lease [Member]
Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block]	Minimum lease payments as of December 31, 2016 under these operating leases are: Year Ending December 31, 2017 $ 97,066 2018 98,524 2019 100,003 2020 41,926 Total $ 337,519

Line of Credit, Notes Payable36

Line of Credit, Notes Payable, Advance, Promissory Note, Convertible Promissory Notes and Long Term Debt (Table)	12 Months Ended
	Dec. 31, 2016
Debt Instruments [Abstract]
Schedule of Long-term Debt Instruments [Table Text Block]	Notes, lines, advances and long term debts are comprised of the following: December 31, 2016 December 31, 2015 Related Related Total Party Total Party Line of credit $ 2,463,736 $ - $ 2,488,753 $ - Unsecured subordinated convertible notes: - - Series A 3,310,500 2,250,000 - - Series B 1,220,634 1,250,000 - - Series V 425,000 300,000 - - Promissory note - related party 2,500,000 2,500,000 1,710,000 1,710,000 Notes payable 375,000 275,000 400,000 300,000 Advances 1,213,027 1,213,027 710,000 710,000 Long term debt - other, current and long term portion 19,573 - 27,833 -
Schedule of Maturities of Long-term Debt [Table Text Block]	which are being amortized as interest expense, are as follow: Non- Year Ending December 31, Amortizing Amortizing * Total 2017 $ 8,525 $ - $ 8,525 2018 5,410 7,575,000 7,580,410 2019 5,200 - 5,200 2020 438 - 438 Total $ 19,573 $ 7,575,000 $ 7,594,573 * Certain non-amortizing notes are subject to earlier maturities. The table above presents all non-amortizing notes at their time period maturity condition.

Equity Incentive Plans (Tables)

Equity Incentive Plans (Tables)	12 Months Ended
	Dec. 31, 2016
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]	On March 1, 2016, the Company granted 371,250 Risk-free interest rate 1.3 - 1.5 % Expected dividend yield 0.00 % Expected volatility 28.8 - 30.3 % Expected term in years 5.0 - 6.0
Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]	The following table summarizes the Company’s stock option activity for the year ended December 31, 2016: Weighted Average Weighted Remaining Average Contractual Number of Exercise Life Aggregate Options Price (in Years) Intrinsic Value Outstanding - December 31, 2015 - - - - Granted 371,250 $ 3.75 9.17 - Exercised - - - - Forfeited or Canceled (7,500) 3.75 - - Outstanding – December 31, 2016 363,750 $ 3.75 9.17 $ - Exercisable – December 31, 2016 90,418 $ 3.75 9.17 $ -
Schedule of Nonvested Share Activity [Table Text Block]	The following table summarizes the Company’s stock option activity for non-vested options for the year ended December 31, 2016: Weighted Average Number of Grant Date Options Fair Value Balance at December 31, 2015 - Granted 371,250 $ 3.75 Vested (90,418) (3.75) Forfeited or Canceled (7,500) (3.75) Balance at December 31, 2016 273,332 $ 3.75
Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity [Table Text Block]	The following table summarizes the Company’s RSU activity for the year ended December 31, 2016: Number of Shares Unvested balance at December 31, 2015 - Granted 347,500 Vested (15,833) Forfeited or Canceled - Unvested balance at December 31, 2016 331,667

Income Taxes (Tables)

Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2016
Income Tax Disclosure [Abstract]
Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]	The following table presents the components of income tax expense (benefit) from operations for the year ended December 31, 2016 and 2015. Year Ended December 31, 2016 2015 US Federal: Deferred $ (1,932,456) $ (1,055,914) State and local: Deferred (681,025) (215,098) Non-US: Deferred (69,203) - Change in valuation allowance 2,682,684 1,271,012 Income tax provision $ - $ -
Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]	The following table presents a reconciliation of differences between the Federal statutory tax rate and the Company’s effective income tax rate for the year ended December 31, 2016 and 2015: Year Ended December 31, 2016 2015 U. S. Federal Statutory rate (34.0) % (34.0) % Non-U.S. losses 0.6 1.0 Losses incurred before change in corporate tax status - 14.3 Local taxes, net of benefit (6.8) (2.8) Other 0.4 - (39.8) (21.5) Change in valuation allowance 39.8 21.5 Effective income tax rate - % - %
Schedule of Deferred Tax Assets and Liabilities [Table Text Block]	The following table presents the Company’s net deferred tax assets and valuation allowance as of December 31, 2016 and 2015: December 31, 2016 2015 Deferred tax assets: Net operating losses - Federal $ 2,341,288 $ 1,067,247 Net operating losses - State 691,582 217,765 Net operating losses - Non-US 69,203 - Stock-based compensation - Federal 246,069 - Stock-based compensation - State 77,440 - Accrued liabilities - Federal 412,346 - Accrued liabilities - State 129,768 - 3,967,696 1,285,012 Deferred tax liabilities: Property and equipment - Federal (11,333) (11,333) Property and equipment - State (2,667) (2,667) (14,000) (14,000) Net deferred tax assets 3,953,696 1,271,012 Valuation allowance (3,953,696) (1,271,012) Net deferred tax assets $ - $ -

Operating Leases (Tables)

Operating Leases (Tables)	12 Months Ended
	Dec. 31, 2016
Research And Development Lease [Member]
Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block]	The research and development office lease commenced in October 2015 2018 Year Ending December 31, 2017 119,480 2018 115,710 2019 100,003 2020 41,926 Total $ 377,119

Supplemental Consolidated Sta40

Supplemental Consolidated Statement of Cash Flows Information (Tables)	12 Months Ended
	Dec. 31, 2016
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION
Schedule of Cash Flow, Supplemental Disclosures [Table Text Block]	Changes in non-cash operating assets and liabilities, as well as other supplemental cash flow disclosures, are as follows: Year Ended December 31, 2016 2015 Changes in operating assets and liabilities: Accounts and note receivable $ 79,743 $ (62,225) Inventory (997,535) (271,171) Prepaid expenses and other assets 42,722 (47,602) Accounts payable 281,787 953,087 Accrued interest payable 640,056 373,608 Accrued expenses 12,800 493,461 Deferred revenue 16,360 653 Customer deposits 11,803 (4,789) Net change in operating assets and liabilities $ 87,736 $ 1,435,022 Supplementary cash flow information: Cash paid during the year for: Interest $ 106,251 $ 91,811 Income taxes - - Supplementary Disclosure of Non-Cash Investing and Financing Activities: Transfer of inventory to leased equipment $ 531,392 $ 233,900 Series V Notes issued in settlement of accounts payable with a related party 300,000 - Accrued interest added to principle of promissory note - related party 263,027 - Conversion of senior promissory notes and related accrued interest into common stock - 829,418 Warrants issued in connection with advisory services - 139,359 Goodwill recognized in connection with Swift Start acquisition - 10,482 Advances to vendors applied to inventory - 44,700 Conversion of promissory notes and related accrued interest into common stock - 1,549,572 Conversion of advances from related party to promissory note - 505,000

Basis of Presentation and Goi41

Basis of Presentation and Going Concern (Details Textual) - USD ($)	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Feb. 29, 2016	Dec. 31, 2014
Basis Of Presentation And Going Concern [Line Items]
Net Income (Loss) Attributable to Parent	$ (6,745,386)	$ (5,001,452)
Operating Income (Loss), Total	(5,924,667)	(4,545,646)
Net Cash Provided by (Used in) Operating Activities, Continuing Operations	(5,181,400)	(3,170,427)
Working Capital Deficit	5,096,220
Stockholders' Equity Attributable to Parent	$ (11,458,100)	$ (5,453,169)		$ (3,147,765)
Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners			51.90%
Chief Executive Officer [Member]
Basis Of Presentation And Going Concern [Line Items]
Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners			20.90%

Summary of Significant Accoun42

Summary of Significant Accounting Policies (Details)	12 Months Ended
	Dec. 31, 2016
Equipment Leased to Other Party [Member] | Maximum [Member]
Property, Plant and Equipment, Useful Life	7 years
Equipment Leased to Other Party [Member] | Minimum [Member]
Property, Plant and Equipment, Useful Life	5 years
Computer Software And Hardware [Member] | Maximum [Member]
Property, Plant and Equipment, Useful Life	5 years
Computer Software And Hardware [Member] | Minimum [Member]
Property, Plant and Equipment, Useful Life	3 years
Vehicles [Member]
Property, Plant and Equipment, Useful Life	5 years
Furniture and Fixtures [Member] | Maximum [Member]
Property, Plant and Equipment, Useful Life	15 years
Furniture and Fixtures [Member] | Minimum [Member]
Property, Plant and Equipment, Useful Life	7 years

Summary of Significant Accoun43

Summary of Significant Accounting Policies (Details Textual) - USD ($)	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Summary Of Significant Accounting Policies [Line Items]
Advertising Expense	$ 61,489	$ 22,218
Shipping, Handling and Transportation Costs	$ 45,973	35,341
Asset Impairment Charges, Total		10,482
Warrant [Member]
Summary Of Significant Accounting Policies [Line Items]
Embedded Derivative, No Longer Bifurcated, Amount Reclassified to Stockholders' Equity		$ 139,359

Acquisitions and Disposals (Det

Acquisitions and Disposals (Details Textual) - USD ($)	1 Months Ended
	May 29, 2015	Dec. 31, 2016	Nov. 29, 2016	Feb. 29, 2016	Dec. 31, 2015	Aug. 06, 2015
Business Acquisition [Line Items]
Common Stock, shares issued		8,229,712			8,229,712
Stock Retired And Cancelled By Interest Holders Of Wholly Owned Subsidiary						8,515,000
Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners				51.90%
Capital Units, Authorized						200,000,000
Increase In Capital Units Authorized Prior Merger						30,000,000
Preferred Stock, Shares Authorized		10,000,000			10,000,000	10,000,000
Preferred Stock, Par or Stated Value Per Share		$ 0.0001			$ 0.0001	$ 0.0001
Common Stock, shares outstanding		8,229,712			8,229,712
Common Stock, par value		$ 0.0001			$ 0.0001	$ 0.0001
Common Stock, shares authorized		20,000,000			20,000,000	20,000,000
Notes, Loans and Financing Receivable, Net, Current, Total		$ 52,043			$ 110,011
Common Stock [Member]
Business Acquisition [Line Items]
Common Stock, shares issued					6,975,000
Swift Start [Member]
Business Acquisition [Line Items]
Goodwill						$ 10,482
Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net, Total						10,500
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents						$ 18
BioHiTech [Member]
Business Acquisition [Line Items]
Common Stock, shares issued					6,975,000
Stock Retired And Cancelled By Interest Holders Of Wholly Owned Subsidiary						8,515,000
Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners						93.00%
Common Stock, shares outstanding						7,500,000
Common Stock, par value						$ 0.0001
CBI Mobile [Member]
Business Acquisition [Line Items]
Sale Price Of Business Operations	$ 290,000
Payments to Acquire Businesses, Gross	75,000
Payments To Acquire Businesses Gross In Form Of Secured Promissory Note	$ 215,000
CBI Mobile [Member] | Secured Debt [Member]
Business Acquisition [Line Items]
Debt Instrument, Interest Rate, Stated Percentage	9.50%		15.00%
QTAG operation [Member]
Business Acquisition [Line Items]
Notes, Loans and Financing Receivable, Net, Current, Total					$ 110,011

Accounts and Note Receivable,45

Accounts and Note Receivable, net (Details) - USD ($)	Dec. 31, 2016	Dec. 31, 2015
Accounts receivable	$ 206,219	$ 271,862
Note receivable (Note 3)	52,043	110,011
Less: allowance for doubtful accounts and note receivable	(118,132)	(65,574)
Accounts Receivable, Net, Current, Total	$ 140,130	$ 316,299

Accounts and Note Receivable,46

Accounts and Note Receivable, net (Details 1) - USD ($)	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Balance at beginning of year	$ 65,574	$ 72,179
Provision for doubtful accounts	93,406	39,247
Amounts written off	(40,848)	(45,852)
Balance at end of year	$ 118,132	$ 65,574

Inventory (Details)

Inventory (Details) - USD ($)	Dec. 31, 2016	Dec. 31, 2015
Inventory [Line Items]
Inventory, Net, Total	$ 706,017	$ 274,304
Equipment [Member]
Inventory [Line Items]
Inventory, Net, Total	191,240	194,791
Parts and Assemblies [Member]
Inventory [Line Items]
Inventory, Net, Total	$ 514,777	$ 79,513

Equipment on Operating Leases48

Equipment on Operating Leases, net (Details) - USD ($)	Dec. 31, 2016	Dec. 31, 2015
Leased equipment	$ 1,870,569	$ 1,601,005
Less: accumulated depreciation	(847,165)	(756,511)
Property Subject to or Available for Operating Lease, Net, Total	$ 1,023,404	$ 844,494

Equipment on Operating Leases49

Equipment on Operating Leases, net (Details 1)	Dec. 31, 2016USD ($)
2,017	$ 693,361
2,018	557,107
2,019	391,611
2,020	243,483
2021 and thereafter	77,362
Total minimum lease income	$ 1,962,924

Equipment on Operating Leases50

Equipment on Operating Leases, net (Details Textual) - USD ($)	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Depreciation	$ 343,628	$ 218,676
Operating Leases, Income Statement, Lease Revenue, Total	1,371,087	1,023,385
Eco Safe digester [Member]
Operating Leases, Income Statement, Lease Revenue, Total	$ 697,965	$ 504,950

Equipment, Fixtures and Vehic51

Equipment, Fixtures and Vehicles, net (Details) - USD ($)	Dec. 31, 2016	Dec. 31, 2015
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Gross	$ 210,992	$ 202,846
Less: accumulated depreciation and amortization	(156,636)	(141,158)
Property, Plant and Equipment, Net, Total	54,356	61,688
Computer Software And Hardware [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Gross	93,543	85,397
Furniture and Fixtures [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Gross	48,196	48,196
Vehicles [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Gross	$ 69,253	$ 69,253

Equipment, Fixtures and Vehic52

Equipment, Fixtures and Vehicles, net (Details Textual) - USD ($)	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Property, Plant and Equipment [Line Items]
Depreciation, Depletion and Amortization, Nonproduction, Total	$ 113,474	$ 141,592
Equipment Fixtures And Vechicles [Member]
Property, Plant and Equipment [Line Items]
Depreciation, Depletion and Amortization, Nonproduction, Total	$ 15,478	$ 24,290

Intangibles Assets, net (Detail

Intangibles Assets, net (Details) - USD ($)	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Indefinite-lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Gross	$ 925,388	$ 925,388
Finite-Lived Intangible Assets, Accumulated Amortization	(658,346)	(560,350)
Finite-Lived Intangible Assets, Net, Total	$ 267,042	$ 365,038
Distribution Rights [Member]
Indefinite-lived Intangible Assets [Line Items]
Finite-Lived Intangible Asset, Useful Life	10 years	10 years
Finite-Lived Intangible Assets, Remaining Amortization Period	2 years 9 months 18 days	3 years 9 months 18 days
Finite-Lived Intangible Assets, Gross	$ 902,000	$ 902,000
Finite-Lived Intangible Assets, Accumulated Amortization	(637,667)	(547,467)
Finite-Lived Intangible Assets, Net, Total	$ 264,333	$ 354,533
Website [Member]
Indefinite-lived Intangible Assets [Line Items]
Finite-Lived Intangible Asset, Useful Life	3 years	3 years
Finite-Lived Intangible Assets, Remaining Amortization Period	3 months 18 days	1 year 3 months 18 days
Finite-Lived Intangible Assets, Gross	$ 23,388	$ 23,388
Finite-Lived Intangible Assets, Accumulated Amortization	(20,679)	(12,883)
Finite-Lived Intangible Assets, Net, Total	$ 2,709	$ 10,505

Intangibles Assets, net (Deta54

Intangibles Assets, net (Details 1) - USD ($)	Dec. 31, 2016	Dec. 31, 2015
Indefinite-lived Intangible Assets [Line Items]
2,017	$ 92,909
2,018	90,200
2,019	43,533
2,020	20,200
2,021	20,200
Total	$ 267,042	$ 365,038

Intangibles Assets, net (Deta55

Intangibles Assets, net (Details Textual) - USD ($)	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Indefinite-lived Intangible Assets [Line Items]
Amortization of Intangible Assets	$ 97,996	$ 117,302

Risk Concentrations (Details)

Risk Concentrations (Details) - USD ($)	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Concentration Risk [Line Items]
Revenue	$ 2,243,466	$ 1,513,981
Non-current tangible assets	1,091,260	957,782
UNITED STATES
Concentration Risk [Line Items]
Revenue	1,681,490	1,398,640
Non-current tangible assets	1,019,664	940,336
International [Member]
Concentration Risk [Line Items]
Revenue	561,976	115,341
Non-current tangible assets	$ 71,596	$ 17,446

Risk Concentrations (Details Te

Risk Concentrations (Details Textual)	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Vendor One [Member] | Shareholder One [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage	1.90%
Vendor Two [Member] | BioHitech International [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage		63.00%
Sales Revenue, Net [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage		10.00%
Sales Revenue, Net [Member] | Shareholder One [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage	10.00%
Sales Revenue, Net [Member] | Shareholder Two [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage	1.90%
Sales Revenue, Net [Member] | Customer Two [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage		13.00%
Sales Revenue, Net [Member] | Major Customer [Member] | Minimum [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage	10.00%	10.00%
Accounts Receivable [Member] | Customer One [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage	22.00%	17.00%
Accounts Receivable [Member] | Customer Two [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage	10.00%	15.00%
Accounts Receivable [Member] | Customer Three [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage		11.00%
Accounts Receivable [Member] | Customer Four [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage	10.00%	10.00%
Accounts Receivable [Member] | Major Customer [Member] | Minimum [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage	10.00%
Accounts Payable [Member] | Vendor One [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage	32.00%
Accounts Payable [Member] | Vendor Two [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage	21.00%	12.00%
Accounts Payable [Member] | Vendor Two [Member] | BioHitech International [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage		37.00%
Accounts Payable [Member] | Vendor [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage		10.00%
Accounts Payable [Member] | Vendor [Member] | Minimum [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage	10.00%
Cost Of Revenue [Member] | Vendor One [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage	32.00%
Cost Of Revenue [Member] | Vendor Two [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage	0.00%	11.00%

Related Party Transactions (Det

Related Party Transactions (Details) - USD ($)		12 Months Ended
		Dec. 31, 2016	Dec. 31, 2015
Assets:
Intangible assets, net		$ 267,042	$ 365,038
Liabilities:
Accounts payable		1,197,277	1,222,167
Accrued interest payable		411,917	287,888
Long term accrued interest		253,000	0
Notes payable		100,000	100,000
Advance from related party		1,213,027	710,000
Promissory note - related parties		275,000	300,000
Other:
S, G & A - Rent expense	[1]	52,657	67,225
Cost of revenues - Rent expense	[1]	42,773	0
S, G & A - Consulting expense	[2]	200,000	200,000
Interest expense		572,345	339,363
Cost of revenue, inventory or equipment on operating leases acquired	[2],[3]	1,355,780	633,819
Series A Convertible Notes [Member]
Liabilities:
Convertible notes - related parties	[4]	2,250,000	0
Series B Convertible Notes [Member]
Liabilities:
Convertible notes - related parties	[5]	1,250,000	0
Series V Convertible Notes [Member]
Liabilities:
Convertible notes - related parties	[6]	300,000	0
Related Party [Member]
Assets:
Intangible assets, net	[2]	264,333	354,533
Liabilities:
Accounts payable		85,374	470,490
Accrued interest payable		390,812	275,517
Long term accrued interest		187,667	0
Notes payable		275,000	300,000
Advance from related party	[7]	1,213,027	710,000
Promissory note - related parties	[8]	2,500,000	1,710,000
Other:
Line of credit guarantee	[9]	$ 2,463,736	$ 2,488,753
[1]	Facility Lease - The Company leases its corporate headquarters and warehouse space from BioHiTech Realty LLC, a company owned by two stockholders of the Company, one of whom is the Chief Executive Officer. The lease expires in 2020, with a renewal option for an additional five-year period.
[2]	Distribution Agreement - BioHiTech has an exclusive license and distribution agreement (the “License Agreement”) with BioHiTech International (“BHT-I”), a company owned by Chun-Il Koh, a BioHiTech shareholder and other unrelated parties. The License Agreement provides distribution rights to the Eco-Safe Digester through December 31, 2023 (unless extended by mutual agreement) and for annual payments to Mr. Koh in the amount of $200,000 for the term of the License Agreement and a 2.5% additional commission on all sales closed by Mr. Koh.
[3]	Inventory Acquisition – During 2016 the Company commenced acquiring certain sub-assemblies for final assembly by the Company from a company controlled by a 1.9% shareholder of BioHiTech.
[4]	Series A Unsecured Subordinated Convertible Notes and Warrants - In connection with the Company’s issuance of unsecured subordinated convertible notes and warrants in 2016, as further disclosed in Note 11, certain related parties participated in such offering.
[5]	Series B Unsecured Subordinated Convertible Notes and Warrants - In connection with the Company’s issuance of unsecured subordinated convertible notes and warrants in 2016, as further disclosed in Note 11, certain related parties participated in such offering.
[6]	Series V Unsecured Subordinated Convertible Notes – In connection with the Company’s issuance of unsecured subordinated convertible notes in 2016, as further disclosed in Note 11, BioHiTech International, see note a, above, exchanged $300,000 in accounts payable by the Company for a $300,000 note.
[7]	Advance from Related Party - The Company’s Chief Executive Officer has advanced the Company funds for operating and capital purposes. The advances bear interest at 13% and are unsecured and due on demand. There are no financial covenants related to this advance and there are no formal commitments to extend any further advances.
[8]	Promissory Note - Related Party - On June 25, 2014, the Company initially entered into a secured promissory note with the Company’s Chief Executive Officer in the aggregate amount of $1,000,000 (the “Promissory Note”). This note has been amended effective July 31, 2015 and January 1, 2016. The amended note provides for up to $2,500,000 in borrowings, an interest rate of 13% per annum, which is subject to prospective reduction to 10% upon the Company’s completion of raising $6,000,000 in connection with an offering of unsecured subordinated convertible notes and warrants and is due on the earlier of (a) a change of control, (b) an event of non-payment default, (c) the two-year anniversary of the Promissory Note, or (d) a Qualified Financing. For purposes of the Promissory Note, a Qualified Financing is defined as the first issuance of debt or equity by the Company through which the Company received gross proceeds of a minimum of $5,000,000 from one or more financial institutions or accredited investors. In connection with the January 1, 2016 amendment, $263,027 of accrued interest was added to the outstanding balance of the note.
[9]	Line of Credit - Under the terms of the line of credit, several related parties have personally guaranteed the line and are contingently liable should the Company not meet its obligations under the line.

Related Party Transactions (D59

Related Party Transactions (Details 1) - Facility Lease [Member]	Dec. 31, 2016USD ($)
2,017	$ 97,066
2,018	98,524
2,019	100,003
2,020	41,926
Total	$ 337,519

Related Party Transactions (D60

Related Party Transactions (Details Textual) - USD ($)	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Jan. 31, 2016	Jun. 25, 2014
Related Party Transaction [Line Items]
Debt Instrument, Interest Rate, Effective Percentage	5.00%
Unsecured Subordinated Convertible Notes And Warrants Offering	$ 6,000,000
Accrued interest payable	411,917	$ 287,888
Increase (Decrease) in Accounts Payable, Total	$ 281,787	953,087
BioHiTech [Member]
Related Party Transaction [Line Items]
Noncontrolling Interest, Ownership Percentage by Parent	1.90%
Series V Convertible Notes [Member]
Related Party Transaction [Line Items]
Convertible Subordinated Debt	$ 425,000	$ 0
Series V Convertible Notes [Member] | BioHiTech [Member]
Related Party Transaction [Line Items]
Convertible Subordinated Debt	300,000
Amended [Member]
Related Party Transaction [Line Items]
Secured Debt			$ 2,500,000
Accrued interest payable	$ 263,027
Chief Executive Officer [Member]
Related Party Transaction [Line Items]
Debt Instrument, Interest Rate, Effective Percentage	13.00%
Mr. Koh [Member]
Related Party Transaction [Line Items]
Percentage Of Commission On Sale Price Of Machinery	2.50%
Secured Debt [Member]
Related Party Transaction [Line Items]
Secured Debt				$ 1,000,000
Debt Instrument, Interest Rate, Effective Percentage	13.00%
Proceeds from Issuance of Debt	$ 5,000,000

Line of Credit, Notes Payable61

Line of Credit, Notes Payable, Advance, Promissory Note, Convertible Promissory Notes and Long Term Debt (Details) - USD ($)		Dec. 31, 2016	Dec. 31, 2015
Debt Instrument [Line Items]
Line of credit		$ 2,463,736	$ 2,488,753
Promissory note - related party		2,500,000	1,710,000
Notes payable		375,000	400,000
Advances		1,213,027	710,000
Long term debt - other, current and long term portion		19,573	27,833
Series A Convertible Notes [Member]
Debt Instrument [Line Items]
Convertible Subordinated Debt		3,310,500	0
Notes payable		3,400,000
Series B ConvertibleNotes [Member]
Debt Instrument [Line Items]
Convertible Subordinated Debt		1,220,634	0
Series V Convertible Notes [Member]
Debt Instrument [Line Items]
Convertible Subordinated Debt		425,000	0
Related Party [Member]
Debt Instrument [Line Items]
Line of credit		0	0
Promissory note - related party		2,500,000	1,710,000
Notes payable		275,000	300,000
Advances	[1]	1,213,027	710,000
Long term debt - other, current and long term portion		0	0
Related Party [Member] | Series A Convertible Notes [Member]
Debt Instrument [Line Items]
Convertible Subordinated Debt		2,250,000	0
Related Party [Member] | Series B ConvertibleNotes [Member]
Debt Instrument [Line Items]
Convertible Subordinated Debt		1,250,000	0
Related Party [Member] | Series V Convertible Notes [Member]
Debt Instrument [Line Items]
Convertible Subordinated Debt		$ 300,000	$ 0
[1]	Advance from Related Party - The Company’s Chief Executive Officer has advanced the Company funds for operating and capital purposes. The advances bear interest at 13% and are unsecured and due on demand. There are no financial covenants related to this advance and there are no formal commitments to extend any further advances.

Line of Credit, Notes Payable62

Line of Credit, Notes Payable, Advance, Promissory Note, Convertible Promissory Notes and Long Term Debt (Details 1) - USD ($)		Dec. 31, 2016	Dec. 31, 2015
2,017		$ 8,525
2,018		7,580,410
2,019		5,200
2,020		438
Total		19,573	$ 27,833
Amortizing [Member]
2,017		8,525
2,018		5,410
2,019		5,200
2,020		438
Total		19,573
Non-Amortizing [Member]
2,017	[1]	0
2,018	[1]	7,575,000
2,019	[1]	0
2,020	[1]	0
Total	[1]	$ 7,575,000
[1]	Certain non-amortizing notes are subject to earlier maturities. The table above presents all non-amortizing notes at their time period maturity condition.

Line of Credit, Notes Payable63

Line of Credit, Notes Payable, Advance, Promissory Note, Convertible Promissory Notes and Long Term Debt (Details Textual) - USD ($)	Feb. 10, 2016	Nov. 18, 2016	Oct. 27, 2015	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Line of Credit Facility, Maximum Borrowing Capacity				$ 2,500,000
Line of Credit Facility, Interest Rate During Period				0.50%
Line of Credit Facility, Interest Rate at Period End				4.25%	4.00%
Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent					120.00%
Debt Instrument, Interest Rate, Effective Percentage				5.00%
Line of Credit Facility, Average Outstanding Amount				$ 2,459,453	$ 2,405,197
Notes Payable, Total				375,000	$ 400,000
Unamortized Debt Issuance Expense				118,866
Unsecured Promissory Notes One [Member]
Debt Instrument, Face Amount				100,000
Unsecured Promissory Notes Two [Member]
Debt Instrument, Face Amount				$ 275,000
Maximum [Member]
Debt Instrument, Interest Rate, Effective Percentage				4.98%
Minimum [Member]
Debt Instrument, Interest Rate, Effective Percentage				1.90%
Weighted Average [Member]
Line of Credit Facility, Interest Rate During Period				4.02%	3.77%
Convertible Promissory Note [Member]
Debt Instrument, Face Amount					$ 500,000	$ 900,000
Convertible Long Term Notes Payable Related Party					$ 1,400,000
Debt Instrument, Interest Rate, Stated Percentage					13.00%
Senior Convertible Promissory Note [Member]
Debt Instrument, Face Amount					$ 800,000
Debt Instrument, Interest Rate, Stated Percentage					9.00%
Debt Instrument, Increase, Accrued Interest			$ 29,418
Conversion of Stock, Shares Converted			236,977
Debt Instrument, Convertible, Conversion Price			$ 3.50
Notes Payable [Member]
Debt Instrument, Interest Rate, Stated Percentage				10.00%
Letter of Credit [Member]
Line of Credit Facility, Maximum Borrowing Capacity				$ 250,000
Convertible Debt [Member]
Proceeds from Issuance Initial Public Offering					$ 4,000,000
Debt Instrument, Increase, Accrued Interest			$ 149,572
Conversion of Stock, Shares Converted			442,735
Debt Instrument, Convertible, Conversion Price			$ 3.50
Accredited Investors [Member] | Senior Convertible Promissory Note [Member]
Proceeds from Issuance Initial Public Offering					$ 5,000,000
Series A Convertible Notes [Member]
Debt Instrument, Convertible, Conversion Price	$ 3.75
Conversion Price of Notes, Percentage	120.00%
Notes Payable, Total				3,400,000
Unamortized Debt Issuance Expense				89,500
Deferred Offering Costs				165,230
Debt Instrument, Maturity Date	Feb. 10, 2018
Series A Convertible Notes [Member] | Unsecured Convertible Debt [Member]
Debt Instrument, Interest Rate, Stated Percentage	8.00%
Accumulated Amortization, Debt Issuance Costs				75,730
Series A Convertible Notes [Member] | Private Placement [Member]
Issuance Of Convertible Promissory Notes And Warrants	$ 3,400,000
Series A Convertible Notes [Member] | Investor [Member] | Private Placement [Member]
Issuance Of Convertible Promissory Notes And Warrants	$ 2,250,000
Series B Convertible Notes [Member]
Debt Instrument, Convertible, Conversion Price		$ 2.75
Issuance Of Convertible Promissory Notes And Warrants		$ 1,250,000
Conversion Price of Notes, Percentage		120.00%
Notes Payable, Total				1,250,000
Unamortized Debt Issuance Expense				29,366
Deferred Offering Costs				30,643
Debt Instrument, Maturity Date		Nov. 18, 2018
Series B Convertible Notes [Member] | Unsecured Convertible Debt [Member]
Debt Instrument, Interest Rate, Stated Percentage		8.00%
Accumulated Amortization, Debt Issuance Costs				$ 1,277
Series V Convertible Notes [Member]
Debt Instrument, Convertible, Conversion Price	$ 3.75
Debt Instrument, Convertible, Terms of Conversion Feature	  (i) Inventory Acquisition – During 2016 the Company commenced acquiring certain sub-assemblies for final assembly by the Company from a company controlled by a 1.9% shareholder of BioHiTech.
Debt Instrument, Maturity Date	Feb. 10, 2018
Series V Convertible Notes [Member] | Unsecured Convertible Debt [Member]
Debt Instrument, Interest Rate, Stated Percentage	8.00%

Equity Transactions (Details Te

Equity Transactions (Details Textual) - USD ($)	Feb. 10, 2016	Dec. 31, 2016	Dec. 31, 2015
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number, Beginning Balance			50,000
Share Price			$ 3.50
Description Of Other Warrants		The warrants allow the holders to acquire up to $80,000 of the Companys common stock at a price of 120% of the closing price of the Companys first issuance of equity in one, or a series of related transactions, through which the Company receives gross process of $5,000,000 or more from one or more financial institutions or accredited investors.
Stock Issued During Period, Shares, Restricted Stock Award, Gross		8,000
Restricted Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted		15,000
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value		$ 2.40
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Additional Shares Granted		10,000
Tusk [Member]
Debt Conversion, Original Debt, Amount		$ 25,000
Tusk [Member] | Series V Convertible Note [Member]
Debt Instrument, Face Amount		$ 125,000
Maxim Warrants [Member]
Percentage Of Warrants Exercisable Of Common Shares	10.00%
Class of Warrant or Right, Exercise Price of Warrants or Rights	$ 3.75
Warrant Expiration Terms	5 years
Barksdale Warrants [Member]
Proceeds from Issuance of Warrants			$ 5,000,000
Warrants To Purchase Of Common Stock			140,000
Warrants and Rights Outstanding			$ 10,744
Fair Value Assumptions, Weighted Average Volatility Rate			50.24%
Fair Value Assumptions, Risk Free Interest Rate			1.42%
Derivative Liability, Fair Value, Gross Asset			$ 14,182

Equity Incentive Plans (Details

Equity Incentive Plans (Details)	12 Months Ended
	Dec. 31, 2016
Risk-free interest rate, Minimum	1.30%
Risk-free interest rate, Maximum	1.50%
Expected dividend yield	0.00%
Expected volatility, Minimum	28.80%
Expected volatility, Maximum	30.30%
Maximum [Member]
Expected term in years	6 years
Minimum [Member]
Expected term in years	5 years

Equity Incentive Plans (Detai66

Equity Incentive Plans (Details 1)	12 Months Ended
	Dec. 31, 2016USD ($)$ / sharesshares
Number of Options, Beginning Balance | shares	0
Number of Options, Granted | shares	371,250
Number of Options, Exercised | shares	0
Number of Options, Forfeited or Canceled | shares	(7,500)
Number of Options, Ending Balance | shares	363,750
Number of Options, Exercisable - December 31, 2016 | shares	90,418
Weighted Average Exercise Price, Beginning Balance | $ / shares	$ 0
Weighted Average Exercise Price, Granted | $ / shares	3.75
Weighted Average Exercise Price, Exercised | $ / shares	0
Weighted Average Exercise Price, Forfeited or Canceled | $ / shares	3.75
Weighted Average Exercise Price, Ending Balance | $ / shares	3.75
Weighted Average Exercise Price, Exercisable - December 31, 2016 | $ / shares	$ 3.75
Weighted Average Remaining Contractual Life (in Years), Granted	9 years 2 months 1 day
Weighted Average Remaining Contractual Life (in Years), Forfeited or Canceled	0 years
Weighted Average Remaining Contractual Life (in Years), Outstanding	9 years 2 months 1 day
Weighted Average Remaining Contractual Life (in Years), Exercisable - December 31, 2016	9 years 2 months 1 day
Aggregate Intrinsic Value, Outstanding - December 31, 2016 | $	$ 0
Aggregate Intrinsic Value, Exercisable - December 31, 2016 | $	$ 0

Equity Incentive Plans (Detai67

Equity Incentive Plans (Details 2)	12 Months Ended
	Dec. 31, 2016$ / sharesshares
Number of Options, Balance at December 31, 2015 | shares	0
Number of Options, Granted | shares	371,250
Number of Options, Vested | shares	(90,418)
Number of Options, Forfeited or Canceled | shares	(7,500)
Number of Options, Balance at December 31, 2016 | shares	273,332
Weighted Average Grant Date Fair Value, Balance at December 31, 2015 | $ / shares
Weighted Average Grant Date Fair Value, Granted | $ / shares	3.75
Weighted Average Grant Date Fair Value, Vested | $ / shares	(3.75)
Weighted Average Grant Date Fair Value, Forfeited or Canceled | $ / shares	(3.75)
Weighted Average Grant Date Fair Value, Balance at December 31, 2016 | $ / shares	$ 3.75

Equity Incentive Plans (Detai68

Equity Incentive Plans (Details 3)	12 Months Ended
	Dec. 31, 2016shares
Unvested balance at December 31, 2015	0
Granted	347,500
Vested	(15,833)
Forfeited or Canceled	0
Unvested balance at December 31, 2016	331,667

Equity Incentive Plans (Detai69

Equity Incentive Plans (Details Textual) - USD ($)	1 Months Ended		12 Months Ended
	Apr. 30, 2016	Apr. 15, 2016	Dec. 31, 2016	Dec. 31, 2015
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross			371,250
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period			15,833
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period			347,500
Stock Granted, Value, Share-based Compensation, Gross			$ 520,210
Stock Issued During Period, Value, Share-based Compensation, Gross			48,953	$ 175,000
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized			$ 263,895
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition			2 years 1 month 6 days
Share Price				$ 3.50
Share-based Compensation, Total			$ 674,782	$ 0
Employee Stock Option [Member]
Stock Issued During Period, Value, Share-based Compensation, Gross			245,635
Restricted Stock Units (RSUs) [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period		15,833
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period	347,500	347,500
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized			$ 978,229
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition			2 years 1 month 28 days
Share Price		$ 4.05
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value	$ 1,407,375
Share-based Compensation, Total			$ 429,146
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Nonvested			$ 746,251
Equity Incentive Plan 2015 [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross			371,250
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized			750,000
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period			38,750

Income Taxes (Details)

Income Taxes (Details) - USD ($)	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Federal:
Deferred	$ (1,932,456)	$ (1,055,914)
State and local:
Deferred	(681,025)	(215,098)
Non-US:
Deferred	(69,203)	0
Change in valuation allowance	2,682,684	1,271,012
Income tax provision	$ 0	$ 0

Income Taxes (Details 1)

Income Taxes (Details 1)	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
U. S. Federal Statutory rate	(34.00%)	(34.00%)
Non-U.S. losses	0.60%	1.00%
Losses incurred before change in corporate tax status	0.00%	14.30%
Local taxes, net of benefit	(6.80%)	(2.80%)
Other	0.40%	0.00%
Effective Income Tax Rate Reconciliation, Other Reconciling Items, Percent, Total	(39.80%)	(21.50%)
Change in valuation allowance	39.80%	21.50%
Effective income tax rate	0.00%	0.00%

Income Taxes (Details 2)

Income Taxes (Details 2) - USD ($)	Dec. 31, 2016	Dec. 31, 2015
Deferred tax assets:
Net operating losses - Federal	$ 2,341,288	$ 1,067,247
Net operating losses - State	691,582	217,765
Net operating losses - Non-US	69,203	0
Stock-based compensation - Federal	246,069	0
Stock-based compensation - State	77,440	0
Accrued liabilities - Federal	412,346	0
Accrued liabilities - State	129,768	0
Deferred Tax Assets, Operating Loss Carryforwards, Total	3,967,696	1,285,012
Deferred tax liabilities:
Property and equipment - Federal	(11,333)	(11,333)
Property and equipment - State	(2,667)	(2,667)
Deferred Tax Assets, Gross, Total	(14,000)	(14,000)
Net deferred tax assets	3,953,696	1,271,012
Valuation allowance	(3,953,696)	(1,271,012)
Net deferred tax assets	$ 0	$ 0

Income Taxes (Details Textual)

Income Taxes (Details Textual)	12 Months Ended
	Dec. 31, 2016USD ($)
Operating Loss Carryforwards [Line Items]
Operating Loss Carryforwards	$ 7,198,649
Operating Loss Carryforwards, Expiration Date	Dec. 31, 2035

Operating Leases (Details)

Operating Leases (Details) - Research And Development Lease [Member]	Dec. 31, 2016USD ($)
Operating Leased Assets [Line Items]
2,017	$ 119,480
2,018	115,710
2,019	100,003
2,020	41,926
Total	$ 377,119

Operating Leases (Details Textu

Operating Leases (Details Textual) - USD ($)		12 Months Ended
		Dec. 31, 2016	Dec. 31, 2015
Operating Leased Assets [Line Items]
Operating Leases, Rent Expense	[1]	$ 52,657	$ 67,225
Research And Development Lease [Member]
Operating Leased Assets [Line Items]
Lessor Leasing Arrangements, Operating Leases, Renewal Term		1 year
Operating Lease Commencement Year		2,015
Operating Lease Expiration Term		2,018
Operating Leases, Rent Expense		$ 128,903	$ 105,925
[1]	Facility Lease - The Company leases its corporate headquarters and warehouse space from BioHiTech Realty LLC, a company owned by two stockholders of the Company, one of whom is the Chief Executive Officer. The lease expires in 2020, with a renewal option for an additional five-year period.

Supplemental Consolidated Sta76

Supplemental Consolidated Statement of Cash Flows Information (Details) - USD ($)	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Changes in operating assets and liabilities:
Accounts and note receivable	$ 79,743	$ (62,225)
Inventory	(997,535)	(271,171)
Prepaid expenses and other assets	42,722	(47,602)
Accounts payable	281,787	953,087
Accrued interest payable	640,056	373,608
Accrued expenses	12,800	493,461
Deferred revenue	16,360	653
Customer deposits	11,803	(4,789)
Net change in operating assets and liabilities	87,736	1,435,022
Supplementary cash flow information:
Interest	106,251	91,811
Income taxes	0	0
Supplementary Disclosure of Non-Cash Investing and Financing Activities:
Transfer of inventory to leased equipment	531,392	233,900
Series V Notes issued in settlement of accounts payable with a related party	300,000	0
Accrued interest added to principle of promissory note - related party	263,027	0
Conversion of senior promissory notes and related accrued interest into common stock	0	829,418
Warrants issued in connection with advisory services	0	139,359
Goodwill recognized in connection with Swift Start acquisition	0	10,482
Advances to vendors applied to inventory	0	44,700
Conversion of promissory notes and related accrued interest into common stock	0	1,549,572
Conversion of advances from related party to promissory note	$ 0	$ 505,000

Subsequent Events (Details Text

Subsequent Events (Details Textual) - USD ($)	Feb. 01, 2017	Jan. 01, 2017	Mar. 31, 2017	Mar. 31, 2017	Dec. 31, 2016	Mar. 21, 2017	Jan. 25, 2017	Dec. 31, 2015	Aug. 06, 2015
Subsequent Event [Line Items]
Common Stock, Shares Authorized					20,000,000			20,000,000	20,000,000
Common Stock, par value (in dollars per share)					$ 0.0001			$ 0.0001	$ 0.0001
Line of Credit Facility, Maximum Borrowing Capacity					$ 2,500,000
Secured Debt [Member]
Subsequent Event [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity					$ 2,500,000
Line of Credit Facility, Expiration Date					Jan. 1, 2018
Subsequent Event [Member]
Subsequent Event [Line Items]
Common Stock, Shares Authorized							50,000,000
Common Stock, par value (in dollars per share)							$ 0.0001
Subsequent Event [Member] | Land [Member]
Subsequent Event [Line Items]
Payments to Acquire Property, Plant, and Equipment			$ 1,092,000
Monthly Payments For First Twelve Month			3,500	$ 3,500
Monthly Payments For Next Twelve Month			$ 6,000	6,000
Subsequent Event [Member] | Entsorga West Virginia LLC [Member]
Subsequent Event [Line Items]
Business Acquisiton Purchase Price For one Percentage Interest		$ 60,000
Business Acquisition, Percentage of Voting Interests Acquired		17.20%				17.20%
Equity Method Investments		$ 1,034,028				$ 1,034,028
Business Acquisiton, Remaining Voting Interest To Be Acquired At Company Option		23.10%
Earnest Money Deposits		$ 25,000,000
Proceeds from Contributed Capital		$ 6,000,000
Subsequent Event [Member] | Entsorga West Virginia LLC [Member] | Maximum [Member]
Subsequent Event [Line Items]
Business Acquisition, Percentage of Voting Interests Acquired		40.00%
Subsequent Event [Member] | Secured Debt [Member]
Subsequent Event [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity	$ 4,500,000
Line of Credit Facility, Expiration Date	Feb. 1, 2019
Subsequent Event [Member] | Executive Equity Incentive 2017 Plan [Member]
Subsequent Event [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized							1,000,000
Subsequent Event [Member] | Unsecured Debt [Member]
Subsequent Event [Line Items]
Long-term Debt, Gross	$ 1,213,027
Subsequent Event [Member] | Series B Convertible Notes [Member]
Subsequent Event [Line Items]
Repayments of Notes Payable				625,000
Subsequent Event [Member] | Series B Convertible Notes [Member] | Officer [Member]
Subsequent Event [Line Items]
Repayments of Notes Payable				$ 500,000